Humanities Assignment

A reflection paper is NOT a research paper.  You should use your own ideas to reflect upon the materials from the learning unit.  Use the information in the learning unit to do the following:

In his essay, John Berger writes that the past is mystified because, for one reason, “history always constitutes the relation between a present and its past.”  Berger continues his discussion by examining the “convention of perspective” which allows the viewer of art to become its sole interpreter.  Of course, the camera has changed the way we view art; it allows us to see other “things” that are not immediately present in a museum.  In both Unit 4.1 and Unit 4.2, the idea of other “things” seem to be the subject of the readings and films.  For instance:

In Unit 4.1, artists are in conversation with each other.  Authors and songwriters provide words for famous paintings.  The words that are provided, however, often reference what is absent from the painting.  For instance, Oates provides a back story for the people in the painting, Waits creates a song that is inspired by the diner, and Ashbery reads into the portrait a landscape/setting, history, and motivation for the artist-as-subject.

In Unit 4.2, both films create a reality that is not possible in the “real world.”  In Six Characters, fictional characters live out a story that hasn’t been written.  In La Moustache, the main character’s world is turned upside down because his memory and his reality exist in conflict – in fact, the viewer may even question what is “true” in that film.

For this reflection paper, you will interpret a selection from 4.1 and 4.2 by doing what the poets do: Choose one painting from 4.1 and one film from 4.2. Then, work to create meaning for the selection by discussing something that is seemingly absent from it. For example: What’s missing from the painting that you think is important and what might Berger say about that?  Or, What’s missing from the reality of the film (or the perceived reality of the film) that is important to understanding it and what might Berger suggest about the way we’re “reading” the film?  Be careful when analyzing the painting; you can not just explain what the poet or the learning unit said about the painting. You need to create your own, unique interpretation.

The submission must be no fewer than two and no more than three pages of double-spaced text in 12pt. font. It must be submitted as a Word, RichText, or PDF file.

source: A reflection paper is NOT a research paper.  You should use your own ideas to reflect upon the materials from the learning unit.  Use the information in the learning unit to do the following:

In his essay, John Berger writes that the past is mystified because, for one reason, “history always constitutes the relation between a present and its past.”  Berger continues his discussion by examining the “convention of perspective” which allows the viewer of art to become its sole interpreter.  Of course, the camera has changed the way we view art; it allows us to see other “things” that are not immediately present in a museum.  In both Unit 4.1 and Unit 4.2, the idea of other “things” seem to be the subject of the readings and films.  For instance:

In Unit 4.1, artists are in conversation with each other.  Authors and songwriters provide words for famous paintings.  The words that are provided, however, often reference what is absent from the painting.  For instance, Oates provides a back story for the people in the painting, Waits creates a song that is inspired by the diner, and Ashbery reads into the portrait a landscape/setting, history, and motivation for the artist-as-subject.

In Unit 4.2, both films create a reality that is not possible in the “real world.”  In Six Characters, fictional characters live out a story that hasn’t been written.  In La Moustache, the main character’s world is turned upside down because his memory and his reality exist in conflict – in fact, the viewer may even question what is “true” in that film.

For this reflection paper, you will interpret a selection from 4.1 and 4.2 by doing what the poets do: Choose one painting from 4.1 and one film from 4.2. Then, work to create meaning for the selection by discussing something that is seemingly absent from it. For example: What’s missing from the painting that you think is important and what might Berger say about that?  Or, What’s missing from the reality of the film (or the perceived reality of the film) that is important to understanding it and what might Berger suggest about the way we’re “reading” the film?  Be careful when analyzing the painting; you can not just explain what the poet or the learning unit said about the painting. You need to create your own, unique interpretation.

The submission must be no fewer than two and no more than three pages of double-spaced text in 12pt. font. It must be submitted as a Word, RichText, or PDF file.

The goal of this assignment is to work with the course materials and your own knowledge to create an understanding of the questions/prompt above. Using web or outside sources will result in a grade of 0.

source: https://youtu.be/pfnX-zgXHBM, Hopper: Narrative Cinema and Art (2:56)

, https://youtu.be/SDo1617aXX4

4.2 films : Six Characters in Search of an Author (1:28:17) and La Moustache (1:25:54)

Disorders Of Hormone Regulation And Musculoskeletal Function

rite a short discussion on one of the topics below!!

This week, we discussed musculoskeletal and endocrine disorders, immobility, and environmental hazards. Select a topic from your readings, outcomes, objectives, concepts, and sub-concepts (below) and present a question that applies to a concept or a disease process, wellness, or illness. Submit your question in the following formats: audio, text, or webcam. Once your comment has been posted, submit responses to your peers’ questions and comments. Consider the outcomes, objectives, and concepts below when formulating your initial question.

Your question and response should explain, illustrate, justify, trace, discuss, compare, contrast, agree or disagree, interpret, evaluate, and summarize.

Weekly Outcomes & Weekly Objectives

  1. Articulate alterations in structure and function of the endocrine and musculoskeletal systems. (CO 1)
  2. Trace the impact that alterations in the endocrine and musculoskeletal systems have on the body. (CO 2)
  3. Summarize the impact of alterations in the endocrine and musculoskeletal systems on homeostasis. (CO 3)
  4. Understand normal endocrine and musculoskeletal system physiology.
  5. Describe common types of endocrine and musculoskeletal system disorders: causes, clinical manifestations, diagnostic tests, and treatments.
  6. Compare and contrast common endocrine and musculoskeletal conditions: causes, clinical manifestations, diagnostic tests, and treatments.
  7. Apply understanding of alterations in the endocrine and musculoskeletal system across the lifespan to formulate care priorities.
  8. Review the musculoskeletal systems function in bone formation, degradation, and homeostasis.
  9. Examine responses to aging and its impact on pathophysiologic changes in the endocrine and musculoskeletal systems.
  10. Describe how heredity and genetics influence pathophysiological alterations in the endocrine and musculoskeletal systems.

Main Topics and Concepts/ Sub-Concepts with Exemplar

  1. Alterations in the endocrine system
    1. Alterations in physical structures
    2. Alterations in function
    3. Cancers of the endocrine system
    4. Pathophysiologic endocrine response to aging
    5. Genetic influences on endocrine system pathology
  2. Alterations in the musculoskeletal system
    1. Alterations in physical structures
    2. Alterations in function
    3. Cancers of the musculoskeletal system
    4. Pathophysiologic musculoskeletal response to aging
    5. Genetic influences on musculoskeletal system pathology
  3. Acid-base imbalance: diabetic ketoacidosis
  4. Acute versus chronic conditions
    1. Thyroid storm
    2. Hyperthyroidism
  5. Cellular regulation: bone degeneration and regeneration
  6. Fluid and electrolyte imbalances: posterior pituitary gland disorders
  7. Pain: osteoarthritis
  8. Functional mobility: muscular dystrophy
  9. Glucose regulation: Cushing’s syndrome
  10. Tissue integrity: diabetic foot ulceration
  11. Inflammation: Hashimoto’s thyroiditis
  12. Genetics: osteoporosis

    SECTION I Pathophysiology: Background and Overview, 1

    CHAPTER 1 Introduction to Pathophysiology, 1

    CHAPTER 2 Fluid, Electrolyte, and Acid-Base Imbalances, 14

    CHAPTER 3 Introduction to Basic Pharmacology and Other Common Therapies, 40

    CHAPTER 4 Pain, 53

    SECTION II Defense/Protective Mechanisms, 65

    CHAPTER 5 Inflammation and Healing, 65

    CHAPTER 6 Infection, 88

    CHAPTER 7 Immunity, 114

    SECTION III Pathophysiology of Body Systems, 142

    CHAPTER 8 Skin Disorders, 142

    CHAPTER 9 Musculoskeletal System Disorders, 161

    CHAPTER 10 Blood and Circulatory System Disorders, 184

    CHAPTER 11 Lymphatic System Disorders, 213

    CHAPTER 12 Cardiovascular System Disorders, 223

    CHAPTER 13 Respiratory System Disorders, 272

    CHAPTER 14 Nervous System Disorders, 325

    CHAPTER 15 Disorders of the Eyes, Ears, and Other Sensory Organs, 385

    CHAPTER 16 Endocrine System Disorders, 400

    CHAPTER 17 Digestive System Disorders, 427

    CHAPTER 18 Urinary System Disorders, 488

    CHAPTER 19 Reproductive System Disorders, 514

    SECTION IV Factors Contributing to Pathophysiology, 545

    CHAPTER 20 Neoplasms and Cancer, 545

    CHAPTER 21 Congenital and Genetic Disorders, 565

    CHAPTER 22 Complications of Pregnancy, 579

    CHAPTER 23 Complications of Adolescence, 588

    CHAPTER 24 Complications of Aging, 597

    Section V Environmental Factors and Pathophysiology, 606

    CHAPTER 25 Immobility and Associated Problems, 606

    CHAPTER 26 Stress and Associated Problems, 611

    CHAPTER 27 Substance Abuse and Associated Problems, 617

    CHAPTER 28 Environmental Hazards and Associated Problems, 624

    Appendices, 631

    Glossary, 654

    Index, 663

     

     

    GOULD’S Pathophysiology for the Health Professions SIXTH EDITION

     

     

    Evolve Student Resources for Gould’s Pathophysiology for the Health Professions, Sixth Edition, include the following:

    • Animations

    • Answer Key for Study Questions in the book

    Activate the complete learning experience that comes with each textbook purchase by registering at

    http://evolve.elsevier.com/Hubert/Goulds/

    YOU’VE JUST PURCHASED

    MORE THAN A TEXTBOOK!

    REGISTER TODAY!

    You can now purchase Elsevier products on Evolve! Go to evolve.elsevier.com/html/shop-promo.html to search and browse for products.

    2015v1.0

     

    http://evolve.elsevier.com/Hubert/Goulds/
    http://evolve.elsevier.com/html/shop-promo.html

     

    GOULD’S Pathophysiology for the Health Professions

    SIXTH EDITION

    Robert J. Hubert, BS Laboratory Coordinator Iowa State University Department of Animal Sciences Ames, Iowa

    Karin C. VanMeter, PhD Independent Consultant, Biomedical

    Sciences Ames, Iowa

     

     

    3251 Riverport Lane St. Louis, Missouri 63043

    GOULD’S PATHOPHYSIOLOGY FOR THE HEALTH PROFESSIONS, SIXTH EDITION

    ISBN: 978-0-323-41442-5

    Copyright © 2018, 2014, 2011, 2006, 2002, 1997 by Saunders, an imprint of Elsevier Inc.

    No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions

    Senior Content Development Manager: Luke Held Content Development Specialist: Jennifer Wade Publishing Services Manager: Julie Eddy Senior Project Manager: Richard Barber Design Direction: Brian Salisbury

    Printed in Canada

    Last digit is the print number: 9 8 7 6 5 4 3 2 1

    Notices

    Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law, no responsibility is assumed by Elsevier, authors, editors or contributors for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein.

    ISBN: 978-0-323-41442-5

     

    http://www.elsevier.com/permissions

     

    We would like to dedicate this book to the memory of Barbara E.

    Gould, MEd. We hope that this book, the legacy of her work, will

    instill her passion for teaching and learning and will continue to

    inspire health profession students and educators worldwide.

    Robert Hubert Karin VanMeter

     

     

    This page intentionally left blank

     

     

    vii

    Reviewers

    Julie Alles, MSCTE, RHIA Assistant Professor/Program Director Health

    Information Management Allied Health Sciences Grand Valley State University Grand Rapids, Michigan

    Zoe Atamanchuk Canada

    Janet Ballard, Med., BSN, RN Director of Allied Health and Practical Nursing EHOVE Adult Career Center Allied Health Department Milan, Ohio

    Jason Berry, MSN, RN Nursing Instructor Nursing Department Winston Salem State University Winston Salem, North Carolina

    Bonnie Carmack, MN, ARNP, NP Adjunct Faculty Seminole State College Department of Health Sciences Sanford, Florida

    Teresa Cowan, DA, BS, MS Department Chair of Health Sciences Baker College of Auburn Hills Health Sciences Department Auburn Hills, Michigan

    Heather Duval-Foote, BAS, RDMS Instructor/Clinical Coordinator Diagnostic Medical

    Sonography The University of Findlay Diagnostic Services Department College of Health Professions Findlay, Ohio

    Daniel F. Muñoz González, MSMLS, MLS(ASCP) CMPBT MB Assistant Professor of Medical Laboratory Sciences,

    Clinical Chemistry, and Molecular Diagnostics Department of Medical Laboratory Sciences School of Health Professions Andrews University Berrien Springs, Michigan

    Marina Hdeib, MA, RDMS Clinical Associate Professor School of Health Professions University of Missouri-Columbia Department of Clinical and Diagnostic Sciences Columbia, Missouri

    Lily Mauer, RPh, BSc. Pharm. PEBC Registered Pharmacist Instructor NorQuest College Allied Health Careers, Faculty of Health and

    Community Studies Edmonton, Alberta, Canada

    Susan Stout, MHS, BS, RN Program Director of Science Baker College of Muskegon, Michigan Department of Health Science Muskegon, Michigan

     

     

    viii

    Preface

    This textbook provides an introduction to pathophysiology for students in a variety of academic programs for the health professions at colleges and universities. Major disorders are described as well as selected additional diseases with the intention of providing information on a broad spectrum of diseases with one or more distinguish- ing features for each. It is anticipated that additional information and resources pertinent to the individual’s professional needs may be added to classroom presenta- tions and assignments. We trust that students will enjoy studying these topics and proceed with enthusiasm to more detailed studies within their individual specialties.

    Organization

    The textbook is organized into five major sections followed by the appendices:

    Section I—Basic Concepts of Disease Processes • Introduction to pathophysiology includes medical

    terminology and basic cellular changes. • Topics such as fluid, electrolyte, and acid-base imbal-

    ances, basic pharmacology and pain are covered. • The core information for each topic is complemented

    by the inclusion of a specific disease/condition as an immediate clinical application at the end of each chapter.

    Section II—Defense/Protective Mechanisms • Topics such as inflammation and healing, infection,

    and immunity are covered. • Specific areas included are a review of body defenses,

    healing involved in specific trauma such as burns, basic microbiology, review of the immune system components, and mechanisms.

    Section III—Pathophysiology of Body Systems • Selection of specific disorders is based on incidence

    and occurrence, as well as on the need to present a variety of pathophysiological processes and etiologies to the student.

    • For major disorders, information is provided on pathophysiology, etiology, clinical manifestations,

    significant diagnostic tests, common treatment modali- ties, and potential complications.

    • Other selected diseases are presented in less detail, but significant, unique features are highlighted.

    Section IV: Factors Contributing to Pathophysiology • Normal physiological changes related to cancer,

    adolescence, pregnancy, and aging, with their relevance and effect on disease processes and the treatment of the affected individual, are described.

    • Specific disorders associated with cancer and the developmental stages are discussed.

    Section V: Environmental Factors and Pathophysiology • Factors such as immobility, stress, substance abuse,

    and environmental hazards are the major components in this section.

    • Effects of the various environmental factors on the various body systems and potential complications beyond physical pathologies are discussed.

    • New research and data are included as these are areas of increasing concern with regard to pathophysiology and patient health.

    Appendices—additional information: • Ready References include lists of anatomic terms,

    abbreviations and acronyms, a selection of diagnostic tests, an example of a medical history, a disease index, and drug index.

    • A glossary and a list of additional resources complete this resource.

    Format and Features

    The basic format as well as the straightforward, concise approach remains unchanged from the previous editions. Some material has been reorganized to improve the flow of information and facilitate comprehension. Many features related to the presentation of information in this textbook continue as before. • Generic learning objectives are included in each chapter.

    Instructors may modify or add applicable objectives for a specific professional program.

     

     

    P R E FAC E ix

    What’s New?

    • Information on specific diseases has been updated throughout.

    • The specific disorders for each body system have been expanded to reflect current trends and research.

    • A broader emphasis on all allied health professions has been incorporated.

    • Sections and chapters have been reorganized to present the student with a building block approach: basic science and how it relates to human biology, the body’s various mechanisms that respond to the disorders/diseases, the general overview of body systems and their specific disorders, other biological factors outside of the physiology of each system that contribute to instances of disorders/disease and, finally, those environmental factors not directly attributed to a biological function or condition that may contribute to pathophysiology throughout a number of body systems.

    • Figures have been updated with new photographs and illustrations to help in the recognition and identification of the various concepts and specific disorders.

    • Tables have been updated with new information that has been made available since the previous edition.

    • Additional resources have been expanded and updated. • Study questions and Think About questions have been

    reviewed and updated to cover new material in the chapter. The Apply Your Knowledge questions have replaced the Challenge questions in the previous editions.

    • The Study Guide associated with this text has been updated to reflect the most recent information regard- ing various disorders.

    Guidelines for Users

    Certain guidelines were developed to facilitate the use of this textbook by students with diverse backgrounds studying in various health science programs. As well as ongoing general changes, some professional groups have developed unique practice models and language. In some disciplines, rapid changes in terminology have occurred, creating difficulty for some students. For example, current terms such as chemical dependency or cognitive impairment have many synonyms, and some of these are included to enable students to relate to a more familiar phrase. To avoid confusion, the common, traditional terminology has been retained in this text. • The recipient of care or service is referred to as a patient. • When a disease entity refers to a group of related

    disorders, discussion focuses on either a typical rep- resentative of the group or on the general characteristics of the group.

    • Key terms are listed at the beginning of the chapter. They are presented in bold print and defined when initially used in the chapter. Key terms are not indicated

    • Cross-references are included, facilitating access to information.

    • In the discussion of a particular disorder, the pathophysi- ology is presented first because this “sets the stage,” describing the basic change(s) in the body. Once the student understands the essence of the problem, he or she can easily identify the role of predisposing factors or causes and relate the resulting signs and symptoms or complications. Diagnostic tests and treatment also follow directly from the pathophysiology.

    • Changes at the cellular level are included when significant.

    • Brief reviews of normal anatomy and physiology are presented at the beginning of each chapter, to remind students of the structures and functions that are fre- quently affected by pathological processes. A review of basic microbiology is incorporated into the chapter on infections. Additional review material, such as the pH scale or the location of body cavities, may be found in the Appendices.

    • Numerous illustrations, including flow charts, schematic diagrams, and photographs, clarify and reinforce textual information, as well as offer an alternative visual learning mode, particularly when complex processes are involved. Illustrations are fully labeled, including anatomical structures and pathologic changes. Different colors may be used in a figure to distinguish between the various stages or factors in a process.

    • Tables summarize information or offer comparisons, which are helpful to the student in selecting the more significant information and for review purposes.

    • Brief reference to diagnostic tests and treatment measures promotes understanding of the changes occurring during a disease.

    • Questions are found in boxes throughout the text to stimulate application and review of new concepts. “Apply Your Knowledge” questions are based on review of normal physiology and its application, “Think About” questions follow each small section of informa- tion, and “Study Questions” are located at the end of each chapter. Questions may relate to simple, factual information, potential applications, or the integration of several concepts. These questions are helpful in alerting a student to points initially overlooked and are useful for student self-evaluation before proceeding to the next section. These features may also serve as a tool for review and test preparation. Brief answers are provided on the Evolve website.

    • Brief, adaptable case studies with questions are incor- porated at the end of many chapters and are intended to provide a basis for discussion in a tutorial, an assignment, or an alternative learning mode. It is expected that specific clinical applications may be added by instructors for each professional group.

    • Chapter summaries precede the review questions in each chapter.

     

     

    x P R E FAC E

    as such in subsequent chapters, but may be found in the glossary at the back of the book.

    • Italics are used to emphasize significant words. • It is assumed that students have studied anatomy and

    physiology prior to commencing a pathophysiology course.

    • Concise, readable style includes sufficient scientific and medical terminology to help the student acquire a professional vocabulary and appropriate communica- tion skills. An effort has been made to avoid over- whelming the student with a highly technical approach or impeding the learning process in a student who comes with little scientific background.

    • The presence of numeric values within textual informa- tion often confuses students and detracts from the basic concepts being presented; therefore, specific numbers are included only when they promote understanding of a principle.

    • Suggested diagnostic tests and treatments are not individualized or necessarily complete but are pre- sented generally to assist the student’s application of the pathophysiology. They are also intended to provide students with an awareness of the impact of certain diseases on a client and of possible modifications in the individualized care required. Diagnostic tests increase student cognizance of the extent of data collection and sifting that may be necessary before making a diagnosis, as well as the importance of monitoring the course of a disease or the response to treatment.

    • A brief introduction to pharmacology is included in Section I and specific drugs are referred to during the discussion of certain disorders. Drugs are identified by generic name, followed by a trade name. Examples provided in the appropriate chapter are not recom- mendations, but are suggested only as frequently used representatives of a drug classification. A drug index with references to the applicable chapter is located in the appendices.

    • Information regarding adverse effects of drugs or other treatment is included when there may be potential problems such as high risk for infection or special precautions required of members of the health care team.

    • Every effort has been made to present current informa- tion and concepts simply but accurately. This content provides the practitioner in a health profession with the prerequisite knowledge to recognize and under- stand a client’s problems and the limitations and implications of certain treatment measures; to reduce exacerbating factors; to participate in preventive programs; and to be an effective member of a health care team. The student will develop a knowledge base from which to seek additional information. Individual instructors may emphasize certain aspects or topics, as is most appropriate for students in a specialty area.

    Resources

    In the textbook: • Selected additional resources are listed in the appen-

    dices in Ready Reference 9. • Reference tables are located inside the front book cover.

    These comprise common normal values for blood, cerebrospinal fluid, and urine; a pH scale for body fluids; a list of blood clotting factors; and diagnostic tests.

    • The chapter introducing pharmacology and therapeu- tics is limited in content, but combined with the brief references to treatments with individual disorders, is intended to complement the pathophysiology. This chapter also introduces a few traditional and non- traditional therapeutic modalities to facilitate the student’s understanding of various therapies and of the impact of diverse treatments on the patient and on care by all members of the health care team. Also included are brief descriptions of a few selected forms of therapy, for example, physiotherapy, in hopes of clarifying the roles of different members of a health care team.

    • The appendices at the back of the textbook are intended to promote effective use of study time. They include:

    • A brief review of anatomical terms describing body cavities and planes with accompanying illustrations as well as basic body movements

    • Selected numerical conversions for temperature, weights, and volumes

    • Lists of anatomical terms and combining forms, common abbreviations, and acronyms; because of the broad scope of pathophysiology, a medical dictionary is a useful adjunct for any student in the health-related professions

    • A brief description with illustrations of common diagnostic tests such as ultrasound and magnetic resonance imaging

    • An example of a medical history, which can be modified to fit the needs of a particular professional group

    • A disease index, with a brief description and references to the relevant chapter

    • A drug index, identifying the principal action and references to the appropriate chapters

    • A list of additional resources; websites consist primarily of health care groups or professional organizations that will provide accurate information and are likely to persist. Additional specific journals and websites are available for individual professions.

    • A glossary, including significant terms used to describe diseases as well as key words

    • Accompanying this textbook and developed for it, the ancillaries available include: A study guide for students provides learning activities

    such as complex test questions, matching exercises, crossword puzzles, diagrams to label, and other assignments

     

     

    P R E FAC E xi

    The interactive Evolve web site includes self-evaluation tools, and can be found at http://evolve.elsevier. com/Hubert/Goulds/

    We appreciate the time and effort of reviewers and users of this text, of sales representatives, and of the editors, who have forwarded comments regarding the first four editions. We have attempted to respond to these suggestions while recognizing that comments come from a variety of perspectives, and there is a need to respect

    the primary focus of this textbook, space constraints, and student concerns.

    We hope that teachers and students will enjoy using this textbook, and that it will stimulate interest in the acquisition of additional knowledge in this dynamic field.

    Robert Hubert Karin VanMeter

     

    http://evolve.elsevier.com/Hubert/Goulds/
    http://evolve.elsevier.com/Hubert/Goulds/

     

    xii

    Acknowledgments

    The authors would like to acknowledge and dedicate this edition to the original author, Barbara E. Gould, who passed away. Dr. Gould always kept “student learning” in the forefront as the guideline for writing this book. We also would like to thank all the editorial and produc- tion staff at Elsevier for their support and encouragement. Furthermore, we would like to thank the reviewers for their valuable input.

    I would first like to thank my co-author and friend Karin VanMeter. This is our third major project together and it is her continued dedication to education and professionalism that has contributed so much to the overall teamwork and fun working relationship that we enjoy. I would also like to thank Dr. Joan Cunnick and all of the faculty and staff in the microbiology program at Iowa State University for all of your encouragement and support. As with any and all challenges I have tackled in my life, I give my love and thanks to my family—my parents, John and Ann, and my sister Donna, for their unwavering love and support throughout my life. Finally, I lift up my thanks to Jesus Christ, my Lord and Savior, who makes this all possible—to Him be the glory and honor forever.

    Robert J. Hubert

    My special thanks goes to my co-author Rob Hubert. He has been my friend and collaborator for many years and I am looking forward to many years of working together. Without him all the projects we have done together would have lacked his incredible insight into the topics we have addressed in this new edition. I also would like to thank my mother, Theresia, and my brother, Hermann, and his family for the love, support, and understanding. To my children, Christine and Andrew—thanks for your continu- ous love.

    Karin C. VanMeter

     

     

    xiii

    SECTION I Pathophysiology: Background and Overview, 1

    CHAPTER 1 Introduction to Pathophysiology, 1 What Is Pathophysiology and Why Study It?, 1

    Understanding Health and Disease, 2 Concept and Scope of Pathophysiology, 2 Beginning the Process: A Medical History, 4 New Developments and Trends, 4 Basic Terminology of Pathophysiology, 5

    Introduction to Cellular Changes, 8 Terms Used for Common Cellular Adaptations,

    8 Cell Damage and Necrosis, 9

    CHAPTER 2 Fluid, Electrolyte, and Acid-Base Imbalances, 14

    Fluid Imbalance, 15 Review of Concepts and Processes, 15 Fluid Excess: Edema, 16 Fluid Deficit: Dehydration, 20 Third-Spacing: Fluid Deficit and Fluid Excess,

    21 Electrolyte Imbalances, 21

    Sodium Imbalance, 21 Potassium Imbalance, 24 Calcium Imbalance, 26 Other Electrolytes, 28

    Acid-Base Imbalance, 29 Review of Concepts and Processes, 29 Control of Serum pH, 30 Acid-Base Imbalance, 32

    Treatment of Imbalances, 36

    CHAPTER 3 Introduction to Basic Pharmacology and Other Common Therapies, 40

    Pharmacology, 40 Basic Principles, 40 Drug Effects, 41 Administration and Distribution of Drugs, 42 Drug Mechanisms and Receptors, 45 Responses, 46 Drug Classifications and Prescriptions, 46

    Traditional Forms of Therapy, 48 Physiotherapy, 48 Occupational Therapy, 48 Speech/Language Therapy, 48 Nutrition/Diet, 48 Registered Massage Therapy, 48

    Contents

    Osteopathy, 48 Chiropractic, 49

    Complementary or Alternative Therapies, 49 Noncontact Therapeutic Touch, 49 Naturopathy, 49 Homeopathy, 49 Herbal Medicine, 49 Aromatherapy, 49 Asian Concepts of Disease and Healing, 49

    CHAPTER 4 Pain, 53 Etiology and Sources of Pain, 53 Structures and Pain Pathways, 54 Physiology of Pain and Pain Control, 55 Characteristics of Pain, 57

    Signs and Symptoms, 57 Young Children and Pain, 57 Referred Pain, 57 Phantom Pain, 57 Pain Perception and Response, 57

    Basic Classifications of Pain, 59 Acute Pain, 59 Chronic Pain, 59 Headache, 59 Central Pain, 60 Neuropathic Pain, 60 Ischemic Pain, 61 Cancer-Related Pain, 61

    Pain Control, 61 Methods of Managing Pain, 61 Anesthesia, 62

    SECTION II Defense/Protective Mechanisms, 65

    CHAPTER 5 Inflammation and Healing, 65 Review of Body Defenses, 66 Review of Normal Capillary Exchange, 67 Physiology of Inflammation, 67

    Definition, 67 Causes, 67 Steps of Inflammation, 67

    Acute Inflammation, 69 Pathophysiology and General Characteristics,

    69 Local Effects, 70 Systemic Effects, 71 Diagnostic Tests, 71 Potential Complications, 72

     

     

    xiv CO N T E N TS

    Chronic Inflammation, 72 Pathophysiology and General

    Characteristics, 72 Potential Complications, 73

    Treatment of Inflammation, 73 Drugs, 73 First Aid Measures, 75 Other Therapies, 75

    Healing, 75 Types of Healing, 75 Healing Process, 76 Factors Affecting Healing, 76 Complications Due to Scar Formation, 78

    Example of Inflammation and Healing, 78 Burns, 78 Classifications of Burns, 79

    CHAPTER 6 Infection, 88 Review of Microbiology, 89

    Microorganisms, 89 Types of Microorganisms, 90 Other Agents of Disease, 99 Resident Flora (Indigenous Normal Flora,

    Resident Microbiota), 99 Principles of Infection, 100

    Transmission of Infectious Agents, 100 Host Resistance, 101 Virulence and Pathogenicity of

    Microorganisms, 102 New Issues Affecting Infections and

    Transmission, 102 Control of Transmission and Infection, 103

    Physiology of Infection, 105 Onset and Development, 105 Patterns of Infection, 106 Signs and Symptoms of Infection, 106 Methods of Diagnosis, 107 Treatment and Antimicrobial Drugs, 107 Example of Infection: Influenza (Flu), 110

    CHAPTER 7 Immunity, 114 Review of the Immune System, 115

    Components of the Immune System, 115 Elements of the Immune System, 115 Immune Response, 118 Diagnostic Tests, 119 Process of Acquiring Immunity, 120 Outcome of Infectious Disease, 121 Emerging and Reemerging Infectious Diseases

    and Immunity, 121 Bioterrorism, 121

    Tissue and Organ Transplant Rejection, 121 Rejection Process, 122 Treatment and Prevention, 122

    Hypersensitivity Reactions, 122 Type I: Allergic Reactions, 123 Type II: Cytotoxic Hypersensitivity, 126 Type III: Immune Complex

    Hypersensitivity, 127 Type IV: Cell-Mediated or Delayed

    Hypersensitivity, 127 Autoimmune Disorders, 128

    Mechanism, 128

    Example: Systemic Lupus Erythematosus, 128

    Immunodeficiency, 131 Causes of Immunodeficiency, 131 Effects of Immunodeficiency, 132 Acquired Immunodeficiency Syndrome, 132

    SECTION III Pathophysiology of Body Systems, 142

    CHAPTER 8 Skin Disorders, 142 Review of the Skin, 143 Resident Microbial Flora, 144 Skin Lesions, 144

    Diagnostic Tests, 146 Skin Inflammatory Disorders, 146

    Contact Dermatitis, 146 Urticaria (Hives), 147 Atopic Dermatitis, 147 Psoriasis, 148 Pemphigus, 149 Scleroderma, 149

    Skin Infections, 150 Bacterial Infections, 150 Viral Infections, 152 Fungal Infections, 154 Other Infections, 155

    Skin Tumors, 157 Malignant Melanoma, 157 Kaposi Sarcoma, 158

    CHAPTER 9 Musculoskeletal System Disorders, 161 Review of the Musculoskeletal

    System, 162 Bone, 162 Skeletal Muscle, 164 Joints, 166 Diagnostic Tests, 166

    Trauma, 167 Fractures, 167

    Bone Disorders, 172 Osteoporosis, 172 Rickets and Osteomalacia, 173 Paget Disease (Osteitis Deformans), 173 Osteomyelitis, 173 Abnormal Curvatures of the Spine, 173 Bone Tumors, 174

    Disorders of Muscle, Tendons, and Ligaments, 175 Muscular Dystrophy, 175 Primary Fibromyalgia Syndrome, 176

    Joint Disorders, 176 Osteoarthritis, 176 Rheumatoid Arthritis, 178 Juvenile Rheumatoid Arthritis, 180 Infectious (Septic) Arthritis, 180 Gout (Gouty Arthritis), 180 Ankylosing Spondylitis, 181 Other Inflammatory Joint Disorders, 182

    CHAPTER 10 Blood and Circulatory System Disorders, 184

    Review of the Circulatory System and Blood, 185

     

     

    CO N T E N TS xv

    Anatomy, Structures, and Components, 185 Blood Vessels, 185 Blood, 186

    Blood Dyscrasias, 195 Anemias, 195 Blood-Clotting Disorders, 204 Myelodysplastic Syndrome, 207

    Neoplastic Blood Disorders, 208 Polycythemia, 208 Leukemias, 208

    CHAPTER 11 Lymphatic System Disorders, 213 Review of the Lymphatic System, 213

    Structures and Function, 213 Composition and Production of Lymph, 215

    Lymphatic Disorders, 217 Lymphomas, 217 Multiple Myeloma or Plasma Cell Myeloma,

    220 Lymphedema, 220 Elephantiasis (Filariasis), 221 Castleman Disease, 221

    CHAPTER 12 Cardiovascular System Disorders, 223 Review of the Cardiovascular System, 224

    Heart, 224 Blood Pressure, 229

    Heart Disorders, 230 Diagnostic Tests for Cardiovascular

    Function, 230 General Treatment Measures for Cardiac

    Disorders, 231 Coronary Artery Disease, Ischemic Heart

    Disease, or Acute Coronary Syndrome, 233

    Cardiac Dysrhythmias (Arrhythmias), 242 Congestive Heart Failure, 245 Young Children With Congestive Heart

    Failure, 249 Congenital Heart Defects, 250 Inflammation and Infection in the

    Heart, 255 Vascular Disorders, 258

    Arterial Disorders, 258 Venous Disorders, 262

    Shock, 264

    CHAPTER 13 Respiratory System Disorders, 272 Review of Structures of the Respiratory

    System, 273 Purpose and General Organization, 273 Structures in the Respiratory System, 273 Ventilation, 275 Gas Exchange, 278 Diagnostic Tests, 280

    General Manifestations of Respiratory Disease, 281

    Common Treatment Measures for Respiratory Disorders, 283

    Infectious Diseases, 283 Upper Respiratory Tract Infections, 283 Lower Respiratory Tract Infections, 286

    Obstructive Lung Diseases, 294

    Cystic Fibrosis, 294 Lung Cancer, 296 Aspiration, 298 Obstructive Sleep Apnea, 300 Asthma, 300

    Chronic Obstructive Pulmonary Disease, 302 Emphysema, 303 Chronic Bronchitis, 307 Bronchiectasis, 307

    Restrictive Lung Disorders, 308 Pneumoconioses, 308

    Vascular Disorders, 309 Pulmonary Edema, 309 Pulmonary Embolus, 309

    Expansion Disorders, 312 Atelectasis, 312 Pleural Effusion, 313 Pneumothorax, 314 Flail Chest, 315 Infant Respiratory Distress Syndrome, 317 Adult or Acute Respiratory Distress

    Syndrome, 319 Acute Respiratory Failure, 320

    CHAPTER 14 Nervous System Disorders, 325 Review of Nervous System Anatomy and

    Physiology, 326 Brain, 326 Spinal Cord, 331 Neurons and Conduction of Impulses, 334 Autonomic Nervous System, 335

    General Effects of Neurologic Dysfunction, 338 Local (Focal) Effects, 338 Supratentorial and Infratentorial Lesions, 338 Left and Right Hemispheres, 338 Level of Consciousness, 338 Motor Dysfunction, 339 Sensory Deficits, 339 Visual Loss: Hemianopia, 339 Language Disorders, 340 Seizures, 341 Increased Intracranial Pressure, 341 Herniation, 343 Diagnostic Tests, 344

    Acute Neurologic Problems, 344 Brain Tumors, 344 Vascular Disorders, 345 Infections, 350 Brain Injuries, 354 Spinal Cord Injury, 358

    Congenital Neurologic Disorders, 363 Hydrocephalus, 363 Spina Bifida, 364 Cerebral Palsy, 365

    Seizure Disorders, 367 Chronic Degenerative Disorders, 370

    Multiple Sclerosis, 370 Parkinson Disease (Paralysis Agitans), 372 Amyotrophic Lateral Sclerosis, 373 Myasthenia Gravis, 374 Huntington Disease, 374

    Dementia, 375

     

     

    xvi CO N T E N TS

    Alzheimer Disease, 375 Other Forms of Dementia, 377

    Mental Disorders, 377 Schizophrenia, 378 Depression, 378 Panic Disorders, 379

    Spinal Cord Disorder, 380 Herniated Intervertebral Disc, 380

    CHAPTER 15 Disorders of the Eyes, Ears, and Other Sensory Organs, 385

    Sensory Receptors, 385 The Eye, 386

    Review of Structure and Function, 386 Diagnostic Tests, 388 Structural Defects, 388 Infections and Trauma, 389 Glaucoma, 390 Cataracts, 392 Detached Retina, 393 Macular Degeneration, 393

    The Ear, 394 Review of Structure and Function, 394 Hearing Loss, 395 Ear Infections, 396 Chronic Disorders of the Ear, 398

    CHAPTER 16 Endocrine System Disorders, 400 Review of the Endocrine System, 400 Endocrine Disorders, 403 Insulin and Diabetes Mellitus, 404

    Type 1 and Type 2 Diabetes, 404 Parathyroid Hormone and Calcium, 413 Pituitary Hormones, 414

    Growth Hormone, 414 Antidiuretic Hormone (Vasopressin), 416 Diabetes Insipidus, 416 Inappropriate Antidiuretic Hormone

    Syndrome, 416 Thyroid Disorders, 417

    Goiter, 417 Hyperthyroidism (Graves Disease), 418 Hypothyroidism, 420 Diagnostic Tests, 420

    Adrenal Glands, 420 Adrenal Medulla, 420 Adrenal Cortex, 421

    CHAPTER 17 Digestive System Disorders, 427 Review of the Digestive System, 428

    Structures and Their Functions, 428 Neural and Hormonal Controls, 433 Digestion and Absorption, 434

    Common Manifestations of Digestive System Disorders, 435 Anorexia, Vomiting, and Bulimia, 435 Diarrhea, 436 Constipation, 437 Fluid and Electrolyte Imbalances, 437 Pain, 438 Malnutrition, 438

    Basic Diagnostic Tests, 439 Common Therapies and Prevention, 439 Upper Gastrointestinal Tract Disorders, 441

    Disorders of the Oral Cavity, 441 Dysphagia, 446 Esophageal Cancer, 448 Hiatal Hernia, 448 Gastroesophageal Reflux Disease, 449 Gastritis, 449 Peptic Ulcer, 451 Gastric Cancer, 454 Dumping Syndrome, 455 Pyloric Stenosis, 456

    Disorders of the Liver and Pancreas, 456 Gallbladder Disorders, 456 Jaundice, 457 Hepatitis, 458 Cirrhosis, 463 Liver Cancer, 467 Acute Pancreatitis, 468 Pancreatic Cancer, 469

    Lower Gastrointestinal Tract Disorders, 469 Celiac Disease, 469 Chronic Inflammatory Bowel Disease, 469 Irritable Bowel Syndrome, 473 Appendicitis, 473 Diverticular Disease, 475 Colorectal Cancer, 476 Intestinal Obstruction, 479 Peritonitis, 482

    CHAPTER 18 Urinary System Disorders, 488 Review of the Urinary System, 489 Structures and Anatomy, 489

    Kidneys, 489 Renal Arteries and Veins, 490

    Incontinence and Retention, 493 Diagnostic Tests, 494

    Urinalysis, 494 Blood Tests, 495 Other Tests, 496

    Diuretic Drugs, 496 Dialysis, 497 Disorders of the Urinary System, 498

    Urinary Tract Infections, 498 Inflammatory Disorders, 500

    Urinary Tract Obstructions, 503 Urolithiasis (Calculi, or Kidney Stones), 503 Hydronephrosis, 504 Tumors, 505

    Vascular Disorders, 505 Nephrosclerosis, 505

    Congenital Disorders, 506 Adult Polycystic Kidney, 507 Wilms Tumor (Nephroblastoma), 507

    Renal Failure, 507 Acute Renal Failure, 507 Chronic Renal Failure, 509

    CHAPTER 19 Reproductive System Disorders, 514 Disorders of the Male Reproductive

    System, 515 Review of the Male Reproductive System, 515 Congenital Abnormalities of the Penis, 516 Disorders of the Testes and Scrotum, 516 Inflammation and Infections, 518

     

     

    CO N T E N TS xvii

    Disorders of the Female Reproductive System, 521 Review of the Female Reproductive

    System, 521 Structural Abnormalities, 525 Menstrual Disorders, 526 Infections and Inflammation, 527 Benign Tumors, 530 Malignant Tumors, 532

    Infertility, 537 Sexually Transmitted Diseases, 538

    Bacterial Infections, 538 Viral Infections, 541 Protozoan Infection, 542

    SECTION IV Factors Contributing to Pathophysiology, 545

    CHAPTER 20 Neoplasms and Cancer, 545 Review of Normal Cells, 546 Benign and Malignant Tumors, 546

    Nomenclature, 547 Characteristics of Benign and Malignant

    Tumors, 547 Malignant Tumors: Cancer, 547 Examples of Malignant Tumors, 561

    Skin Cancer, 561 Ovarian Cancer, 561 Brain Cancer, 561 Cancer Incidences, 563

    CHAPTER 21 Congenital and Genetic Disorders, 565 Review of Genetic Control, 565 Congenital Anomalies, 567 Genetic Disorders, 570

    Single-Gene Disorders, 570 Chromosomal Disorders, 572 Multifactorial Disorders, 572

    Developmental Disorders, 573 Diagnostic Tools, 574 Genetic Technology, 575

    Genetic Engineering and Gene Therapy, 575 Genetic Diagnosis and DNA Testing, 575 Proteomic Research and Designer

    Drugs, 576 Down Syndrome, 576

    CHAPTER 22 Complications of Pregnancy, 579 Embryonic and Fetal Development, 579 Physiologic Changes During Pregnancy, 580

    Diagnosis of Pregnancy, 580 Physiologic Changes and Their Implications,

    581 Potential Complications of Pregnancy, 583

    Ectopic Pregnancy, 583 Preeclampsia and Eclampsia:

    Pregnancy-Induced Hypertension, 583 Gestational Diabetes Mellitus, 583 Placental Disorders, 584 Blood Clotting Disorders, 584 Rh Incompatibility, 584 Infection, 585 Adolescent Pregnancy, 586

    CHAPTER 23 Complications of Adolescence, 588 Review of Changes During Adolescence, 588 Obesity and Metabolic Syndrome, 589 Musculoskeletal Abnormalities, 590

    Kyphosis and Lordosis, 590 Scoliosis, 590 Osteomyelitis, 591 Juvenile Rheumatoid Arthritis, 591 Eating Disorders, 593 Anorexia Nervosa, 593 Bulimia Nervosa, 593

    Skin Disorders, 593 Acne Vulgaris, 593

    Infection, 594 Infectious Mononucleosis, 594

    Disorders Affecting Sexual Development, 595 Chromosomal Disorders, 595 Tumors, 595 Menstrual Abnormalities, 595

    CHAPTER 24 Complications of Aging, 597 The Aging Process, 597 Physiological Changes With Aging, 598

    Hormonal Changes, 598 Reproductive System Changes, 598 Changes in the Skin and Mucosa, 599 Cardiovascular System Changes, 599 Musculoskeletal System Changes, 600 Respiratory System Changes, 601 Nervous System Changes, 602 Digestive System Changes and Nutrition, 602 Urinary System Changes, 603

    Other Factors, 603 Multiple Disorders, 603

    Section V Environmental Factors and Pathophysiology, 606

    CHAPTER 25 Immobility and Associated Problems, 606 Factors Involving Immobility, 606 Musculoskeletal System Effects, 607 Cutaneous Effects, 607 Cardiovascular System Effects, 608 Respiratory System Effects, 608 Digestive System Effects, 609 Urinary System Effects, 609 Neurologic/Psychological Effects, 609 Effects of Immobility on Children, 610

    CHAPTER 26 Stress and Associated Problems, 611 Review of the Stress Response, 611 Stress and Disease, 612

    Potential Effects of Prolonged or Severe Stress, 614

    Coping With Stress, 615

    CHAPTER 27 Substance Abuse and Associated Problems, 617

    Terminology, 618 Predisposing Factors, 619 Environmental/Behavioral Risk Factors, 619 Indications/Recognition of Abuse, 620 Potential Complications of Substance Abuse, 620

     

     

    xviii CO N T E N TS

    Overdose, 620 Withdrawal, 621 Effects on Pregnancy, 621 Cardiovascular Problems, 621 Infection, 621 Neurologic/Psychological Effects, 621 Alcohol, 621

    Treatment for Substance Abuse, 622

    CHAPTER 28 Environmental Hazards and Associated Problems, 624

    Chemicals, 625 Heavy Metals, 626 Acids/Bases, 626 Inhalants, 626 Asbestos, 627 Pesticides, 627

    Physical Agents, 627 Temperature Hazards, 627 Radiation Hazards, 628 Noise Hazards, 629 Food and Waterborne Hazards, 629

    Biologic Agents, 629 Bites and Stings, 629

    Appendices, 631

    Glossary, 654

    Index, 663

     

     

    1

    Introduction to Pathophysiology

    S E C T I O N I

    Pathophysiology: Background and Overview

    C H A P T E R 1

    What Is Pathophysiology and Why Study It? Understanding Health and Disease Concept and Scope of Pathophysiology Beginning the Process: A Medical

    History New Developments and Trends

    Basic Terminology of Pathophysiology The Disease Process Etiology-Causes of Disease Characteristics of Disease Disease Prognosis

    Introduction to Cellular Changes

    Terms Used for Common Cellular Adaptations

    Cell Damage and Necrosis Case Studies Chapter Summary Study Questions

    C H A P T E R O U T L I N E

    After studying this chapter, the student is expected to:

    1. Explain the role of pathophysiology in the diagnosis and treatment of disease.

    2. Use the terminology appropriate for pathophysiology. 3. Explain the importance of a patient’s medical history. 4. Describe common cellular adaptations and possible reasons

    for the occurrence of each.

    5. Identify precancerous cellular changes. 6. List the common causes of cell damage. 7. Describe the common types of cell necrosis and possible

    outcomes.

    L E A R N I N G O B J E C T I V E S

    anaerobic apoptosis autopsy biopsy endogenous exogenous

    gangrene homeostasis hypoxia iatrogenic idiopathic inflammation

    ischemia lysis lysosomal microorganisms microscopic morphologic

    necrosis probability pyroptosis

    K E Y T E R M S

    What Is Pathophysiology and Why Study It?

    Pathophysiology involves the study of functional or physi- ologic changes in the body that result from disease processes. This subject builds on knowledge of the normal structure and function of the human body. Disease

    development and the associated changes to normal anatomy or physiology may be obvious or may be hidden with its quiet beginning at the cellular level. As such, pathophysiology includes some aspects of pathology, the laboratory study of cell and tissue changes associated with disease.

     

     

    2 SECTION I Pathophysiology: Background and Overview

    position, and even emotions. Therefore it is impossible to state a single normal value for blood pressure or pulse rate. It is also important to remember that any one indica- tor or lab value must be considered within the total assessment for the individual client.

    Likewise, a discussion of a specific disease in a text presents a general description of the typical characteristics of that disease, but some differences in the clinical picture can be expected to occur in a specific individual, based on similar variables.

    Concept and Scope of Pathophysiology Pathophysiology requires the use of knowledge of basic anatomy and physiology and is based on a loss of or a change in normal structure and function. This basis also saves relearning many facts! Many disorders affecting a particular system or organ—for example, the liver— display a set of common signs and symptoms directly related to that organ’s normal structure and function. For example, when the liver is damaged, many clotting factors cannot be produced; therefore excessive bleeding results. Jaundice, a yellow color in the skin, is another sign of liver disease, resulting from the liver’s inability to excrete bilirubin. Also, basic pathophysiologic concepts related to the causative factors of a disease, such as the processes of inflammation or infection, are common to many diseases. Inflammation in the liver causes swelling of the tissue and stretching of the liver capsule, resulting in pain, as does inflammation of the kidneys. This cause- and-effect relationship, defined by signs and symptoms, facilitates the study of a specific disease.

    To provide a comprehensive overview of disease processes, this text focuses on major diseases. Other disorders are included when appropriate to provide exposure to a broad range of diseases. The principles illustrated by these diseases can then be applied to other conditions encountered in practice. In addition, a general approach is used to describe diseases in which there may be several subtypes. For example, only one type of glomerulonephritis, a kidney disease, is described in the text—acute poststreptococcal glomerulonephritis, which represents the many forms of glomerulonephritis.

    Prevention of disease has become a primary focus in health care. The known causes of and factors predisposing to specific diseases are being used in the development of more effective preventive programs, and it is important to continue efforts to detect additional significant factors and gather data to further decrease the incidence of certain diseases. The Centers for Disease Control and Prevention in the United States have a significant role in collection of data about all types of disease and provide evidence- based recommendations for prevention. Prevention includes activities such as maintaining routine vaccination programs and encouraging participation in screening programs such as blood pressure clinics and vision screening (Box 1.2). As more community health programs

    Understanding Health and Disease Disease may be defined as a deviation from the normal structure or function of any part, organ, system (or combination of these), or from a state of wellness. The World Health Organization includes physical, mental, and social well-being in its definition of health.

    A state of health is difficult to define because the genetic differences among individuals as well as the many varia- tions in life experiences and environmental influences create a variable base. The context in which health is measured is also a consideration. A person who is blind can be in good general health. Injury or surgery may create a temporary impairment in a specific area, but the person’s overall health status is not altered.

    Homeostasis is the maintenance of a relatively stable internal environment regardless of external changes. Disease develops when significant changes occur in the body, leading to a state in which homeostasis cannot be maintained without intervention. Under normal condi- tions homeostasis is maintained within the body with regard to factors such as blood pressure, body temperature, and fluid balance. As frequent minor changes occur in the body, the compensation mechanisms respond, and homeostasis is quickly restored. Usually the individual is not aware of these changes or the compensations taking place.

    Steps to Health (Box 1.1) are recommended to prevent disease.

    When one is defining “normal” limits for health indicators such as blood pressure, pulse, or laboratory data, the values used usually represent an average or a range. These values represent what is expected in a typical individual but are not absolutes. Among normal healthy individuals, the actual values may be adjusted for factors such as age, gender, genetics, environment, and activity level. Well-trained athletes often have a slower pulse or heart rate than the average person. Blood pressure usually increases slightly with age, even in healthy individuals. Also, small daily fluctuations in blood pressure occur as the body responds to minor changes in activity, body

    1. Be a nonsmoker and avoid second-hand smoke. 2. Eat 5 to 10 servings of vegetables and fruit a day. Choose

    high-fiber, lower-fat foods. If you drink alcohol, limit your intake to one to two drinks a day.

    3. Be physically active on a regular basis. This will also help you to maintain a healthy body weight.

    4. Protect yourself and your family from the sun. 5. Follow cancer screening guidelines. 6. Visit your doctor or dentist if you notice any change in

    your normal state of health. 7. Follow health and safety instructions at home and at work

    when using, storing, and disposing of hazardous materials.

    BOX 1.1 Seven Steps to Health

     

     

    CHAPTER 1 Introduction to Pathophysiology 3

    the pathophysiology of a disease, comprehension of its manifestations and potential complications, and its treat- ment, usually follow. A solid knowledge base enables health care professionals to meet these increased demands with appropriate information.

    Individuals working in health care have found that many new scientific developments have raised ethical, legal, and social issues. For example, the explosion in genetic information and related technologies has raised many ethical concerns (see Chapter 21). In relatively new areas of research such as genetics, discussion and resolu- tion of the legal and ethical issues lag far behind the scientific advances. Health research is most often funded by commercial sources (up to 80% according to some studies), and new breakthrough therapies are often announced before the start of any clinical trials. This causes increased hope and immediate demand for such treatments often as much as a decade before they become available. Understanding the research process and the time required for clinical trials of new therapies is crucial for answering questions about new therapies.

    The research process in the health sciences is a lengthy three-stage process that aims to demonstrate both the safety and effectiveness of a new therapy:

    • The first stage in this process is often referred to as “basic science” in which researchers work to identify a technology that will limit or prevent the disease process. This stage is carried out in the laboratory and often requires the use of animals or cell cultures.

    • The second stage involves a small number of human subjects to determine if the therapy is safe for humans.

    • The third stage only takes place if the results of the previous research are positive; the majority of therapies do not make it to this point. In the third stage of research, a large number of patients with the disease or at risk for the disease are enrolled in clinical trials. These are usually double blind studies in which the research subject and the person administering the treatment do not know if the subject is receiving a standard, proven therapy or the therapy being tested. The subject is identified by number only without the particular therapy administered. All results are recorded by the sub- ject’s identification number. The principal investiga- tor is responsible for tracking data collected in trials with many patients, often in several different health centers. The data are then analyzed to determine if the new therapy is more effective than the tradi- tional therapy. In studies of vaccines or other preven- tive measures, data are collected about the occurrence of disease in both the control group and the experimental group to determine if the new measure reduces the incidence of the specific disease.

    Research findings that demonstrate merit after this three- stage process are often referred to as “evidence-based research findings.” The research data collected up to this

    develop, and with the increase in information available on the Internet, health care workers are becoming more involved in responding to questions from many sources and have an opportunity to promote appropriate preven- tive measures in their communities. A sound knowledge of pathophysiology is the basis for preventive teaching in your profession.

    While studying pathophysiology, the student becomes aware of the complexity of many diseases, the difficulties encountered in diagnosis and treatment, and the possible implications arising from a list of signs and symptoms or a prognosis. Sophisticated and expensive diagnostic tests are now available. The availability of these tests, however, also depends on the geographic location of individuals, including their access to large, well-equipped medical facilities. More limited resources may restrict the number of diagnostic tests available to an individual, or a long waiting period may be necessary before testing and treatment are available. When a student understands the pathophysiology, comprehension of the manifestations and potential complications of a disease, and its treatment,

    From http://www.iwh.on.ca/wrmb/primary-secondary-and-tertiary-prevention.

    Primary Prevention The goal is to protect healthy people from developing a disease or experiencing an injury in the first place. For example: • Education about good nutrition, the importance of

    regular exercise, and the dangers of tobacco, alcohol, and other drugs

    • Education and legislation about proper seat belt and helmet use

    • Regular exams and screening tests to monitor risk factors for illness

    • Immunization against infectious disease • Controlling potential hazards at home and in the

    workplace

    Secondary Prevention These interventions happen after an illness or serious risk factors have already been diagnosed. The goal is to halt or slow the progress of disease (if possible) in its earliest stages; in the case of injury, goals include limiting long-term disability and preventing reinjury. For example: • Telling people to take daily, low-dose aspirin to prevent a

    first or second heart attack or stroke • Recommending regular exams and screening tests in

    people with known risk factors for illness • Providing suitably modified work for injured workers

    Tertiary Prevention This phase focuses on helping people manage complicated, long-term health problems such as diabetes, heart disease, cancer, and chronic musculoskeletal pain. The goals include preventing further physical deterioration and maximizing quality of life. For example: • Cardiac or stroke rehabilitation programs • Chronic pain management programs • Patient support groups

    BOX 1.2 Primary, Secondary, and Tertiary Prevention

     

    http://www.iwh.on.ca/wrmb/primary-secondary-and-tertiary-prevention

     

    4 SECTION I Pathophysiology: Background and Overview

    Clinical research funding is being directed to identifying treatments as well as preventive measures that are more effective on a cost-per-patient basis.

    Many options other than traditional therapies are now available. Treatment by acupuncture or naturopathy may be preferred (see Chapter 3). These options may replace traditional therapies or may be used in conjunction with them. A patient may seek an alternative or complementary mode of treatment to supplement traditional care; thus knowledge of these complementary therapies is often needed. It is also recognized that such therapies and practices should be part of a health history for any client seeking care.

    Beginning the Process: A Medical History Many individuals in the health professions will be contributing to, completing, or updating a patient’s medical or health history (see Ready Reference 6 for an example). This information is essential to identify any impact health care activities might have on a patient’s condition, or how a patient’s illness might complicate care. The assessment includes questions on current and prior illnesses, allergies, hospitalizations, and treatment. Current health status is particularly important and should include specific difficulties and any type of therapy or drugs, prescription, nonprescription, and herbal items, including food supplements.

    A basic form is usually provided for the patient to fill out, and then it is completed by the health professional asking appropriate follow-up questions to clarify the patient’s current condition and identify any potential problems. Knowledge of pathophysiology is essential to developing useful questions, understanding the implica- tions of this information, and deciding on the necessary precautions or modifications required to prevent complica- tions. For example, a patient with severe respiratory problems or congestive heart failure would have difficulty breathing in a supine position. Reducing stress may be important for a patient with high blood pressure. Pro- phylactic medication may be necessary for some patients to prevent infection or excessive bleeding. In some cases, additional problems or undesirable effects of medications may be detected.

    New Developments and Trends Both students and practitioners must constantly update their information and knowledge. Developments in all areas of health care are occurring at a rapid rate primarily due to changes in technologies. New causes of disease and more detail regarding the pathophysiology of a disorder are uncovered, diagnostic tests are improved, and more effective drugs are formulated. Technology has greatly altered many aspects of health care.

    Extensive research projects continue in efforts to prevent, control, or cure many disorders. For example,

    point are then passed on to regulatory bodies such as the Food and Drug Administration for review. If the therapy is deemed safe and better than the standard therapy used in the past, the data will be approved for use for the specific disease identified in the research protocol.

    Evidence-based research does not take into account cost, availability, or social and cultural factors that may influence use and acceptance of a therapy. These factors may be quite significant and affect the physician’s or patient’s acceptance of a therapy.

Discussion- Autism & Law

rofessional and Ethical Compliance Code for Behavior Analysts

BEHAVIOR ANALYST CERTIFICATION BOARD® =

=

®

The Behavior Analyst Certification Board’s (BACB’s) Professional and Ethical Compliance Code for Behavior Analysts (the “Code”) consolidates, updates, and replaces the BACB’s Professional Disciplinary and Ethical Standards and Guidelines for Responsible Conduct for Behavior Analysts. The Code includes 10 sections relevant to professional and ethical behavior of behavior analysts, along with a glossary of terms. Effective January 1, 2016, all BACB applicants and certificants will be required to adhere to the Code.

_________________________

In the original version of the Guidelines for Professional Conduct for Behavior Analysts, the authors acknowledged ethics codes from the following organizations: American Anthropological Association, American Educational Research Association, American Psychological Association, American Sociological Association, California Association for Behavior Analysis, Florida Association for Behavior Analysis, National Association of Social Workers, National Association of School Psychologists, and Texas Association for Behavior Analysis. We acknowledge and thank these professional organizations that have provided substantial guidance and clear models from which the Code has evolved.

Approved by the BACB’s Board of Directors on August 7, 2014.

This document should be referenced as: Behavior Analyst Certification Board. (2014). Professional and ethical compliance code for behavior analysts. Littleton, CO: Author.

© 2014 Behavior Analyst Certification Board,® Inc. (BACB®), all rights reserved. Ver. March 18, 2019.

 

 

2

=

=

®

Contents

1.0 1.01 1.02 1.03 1.04 1.05 1.06 1.07

2.0 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15

3.0 3.01 3.02 3.03 3.04 3.05

4.0 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11

Responsible Conduct of Behavior Analysts Reliance on Scientific Knowledge Boundaries of Competence Maintaining Competence through Professional Development Integrity Professional and Scientific Relationships Multiple Relationships and Conflicts of Interest Exploitative Relationships

Behavior Analysts’ Responsibility to Clients Accepting Clients Responsibility Consultation Third-Party Involvement in Services Rights and Prerogatives of Clients Maintaining Confidentiality Maintaining Records Disclosures Treatment/Intervention Efficacy Documenting Professional Work and Research Records and Data Contracts, Fees, and Financial Arrangements Accuracy in Billing Reports Referrals and Fees Interrupting or Discontinuing Services

Assessing Behavior Behavior-Analytic Assessment Medical Consultation Behavior-Analytic Assessment Consent Explaining Assessment Results Consent-Client Records

Behavior Analysts and the Behavior-Change Program Conceptual Consistency Involving Clients in Planning and Consent Individualized Behavior-Change Programs Approving Behavior-Change Programs Describing Behavior-Change Program Objectives Describing Conditions for Behavior-Change Program Success Environmental Conditions that Interfere with Implementation Considerations Regarding Punishment Procedures Least Restrictive Procedures Avoiding Harmful Reinforcers Discontinuing Behavior-Change Programs and Behavior-Analytic Services

 

 

3

=

=

®

Contents, continued

5.0 5.01 5.02 5.03 5.04 5.05 5.06 5.07

6.0 6.01 6.02

7.0 7.01 7.02

8.0 8.01 8.02 8.03 8.04 8.05 8.06

9.0 9.01 9.02 9.03 9.04 9.05 9.06 9.07 9.08 9.09

Behavior Analysts as Supervisors Supervisory Competence Supervisory Volume Supervisory Delegation Designing Effective Supervision and Training Communication of Supervision Conditions Providing Feedback to Supervisees Evaluating the Effects of Supervision

Behavior Analysts’ Ethical Responsibility to the Profession of Behavior Analysts Affirming Principles Disseminating Behavior Analysis

Behavior Analysts’ Ethical Responsibility to Colleagues Promoting an Ethical Culture Ethical Violations by Others and Risk of Harm

Public Statements Avoiding False or Deceptive Statements Intellectual Property Statements by Others Media Presentations and Media-Based Services Testimonials and Advertising In-Person Solicitation

Behavior Analysts and Research Conforming with Laws and Regulations Characteristics of Responsible Research Informed Consent Using Confidential Information for Didactic or Instructive Purposes Debriefing Grant and Journal Reviews Plagiarism Acknowledging Contributions Accuracy and Use of Data

10.0 Behavior Analysts’ Ethical Responsibility to the BACB 10.01 Truthful and Accurate Information Provided to the BACB 10.02 Timely Responding, Reporting, and Updating of Information Provided to the BACB 10.03 Confidentiality and BACB Intellectual Property 10.04 Examination Honesty and Irregularities 10.05 Compliance with BACB Supervision and Coursework Standards 10.06 Being Familiar with This Code 10.07 Discouraging Misrepresentation by Non-Certified Individuals

 

 

4

=

=

®

1.0 Responsible Conduct of Behavior Analysts.

Behavior analysts maintain the high standards of behavior of the profession.

1.01 Reliance on Scientific Knowledge. Behavior analysts rely on professionally derived knowledge based on science and behavior analysis when making scientific or professional judgments in human service provision, or when engaging in scholarly or professional endeavors.

1.02 Boundaries of Competence.

(a) All behavior analysts provide services, teach, and conduct research only within the boundaries of their competence, defined as being commensurate with their education, training, and supervised experience.

(b) Behavior analysts provide services, teach, or conduct research in new areas (e.g., populations, techniques, behaviors) only after first undertaking appropriate study, training, supervision, and/or consultation from persons who are competent in those areas.

1.03 Maintaining Competence through Professional Development.

Behavior analysts maintain knowledge of current scientific and professional information in their areas of practice and undertake ongoing efforts to maintain competence in the skills they use by reading the appropriate literature, attending conferences and conventions, participating in workshops, obtaining additional coursework, and/or obtaining and maintaining appropriate professional credentials.

1.04 Integrity.

(a) Behavior analysts are truthful and honest and arrange the environment to promote truthful and honest behavior in others.

(b) Behavior analysts do not implement contingencies that would cause others to engage in fraudulent, illegal, or unethical conduct.

(c) Behavior analysts follow through on obligations, and contractual and professional commitments with high quality work and refrain from making professional commitments they cannot keep.

(d) Behavior analysts’ behavior conforms to the legal and ethical codes of the social and professional community of which they are members. (See also, 10.02a Timely Responding, Reporting, and Updating of Information Provided to the BACB)

(e) If behavior analysts’ ethical responsibilities conflict with law or any policy of an organization with which they are affiliated, behavior analysts make known their commitment to this Code and take steps to resolve the conflict in a responsible manner in accordance with law.

Professional and Ethical Compliance Code for Behavior Analysts

 

 

5

=

=

®

1.05 Professional and Scientific Relationships. (a) Behavior analysts provide behavior-analytic services only in the context of a defined, professional,

or scientific relationship or role. (b) When behavior analysts provide behavior-analytic services, they use language that is fully

understandable to the recipient of those services while remaining conceptually systematic with the profession of behavior analysis. They provide appropriate information prior to service delivery about the nature of such services and appropriate information later about results and conclusions.

(c) Where differences of age, gender, race, culture, ethnicity, national origin, religion, sexual orientation, disability, language, or socioeconomic status significantly affect behavior analysts’ work concerning particular individuals or groups, behavior analysts obtain the training, experience, consultation, and/or supervision necessary to ensure the competence of their services, or they make appropriate referrals.

(d) In their work-related activities, behavior analysts do not engage in discrimination against individuals or groups based on age, gender, race, culture, ethnicity, national origin, religion, sexual orientation, disability, language, socioeconomic status, or any basis proscribed by law.

(e) Behavior analysts do not knowingly engage in behavior that is harassing or demeaning to persons with whom they interact in their work based on factors such as those persons’ age, gender, race, culture, ethnicity, national origin, religion, sexual orientation, disability, language, or socioeconomic status, in accordance with law.

(f) Behavior analysts recognize that their personal problems and conflicts may interfere with their effectiveness. Behavior analysts refrain from providing services when their personal circumstances may compromise delivering services to the best of their abilities.

1.06 Multiple Relationships and Conflicts of Interest.

(a) Due to the potentially harmful effects of multiple relationships, behavior analysts avoid multiple relationships.

(b) Behavior analysts must always be sensitive to the potentially harmful effects of multiple relationships. If behavior analysts find that, due to unforeseen factors, a multiple relationship has arisen, they seek to resolve it.

(c) Behavior analysts recognize and inform clients and supervisees about the potential harmful effects of multiple relationships.

(d) Behavior analysts do not accept any gifts from or give any gifts to clients because this constitutes a multiple relationship.

1.07 Exploitative Relationships.

(a) Behavior analysts do not exploit persons over whom they have supervisory, evaluative, or other authority such as students, supervisees, employees, research participants, and clients.

 

 

6

=

=

®

(b) Behavior analysts do not engage in sexual relationships with clients, students, or supervisees, because such relationships easily impair judgment or become exploitative.

(c) Behavior analysts refrain from any sexual relationships with clients, students, or supervisees, for at least two years after the date the professional relationship has formally ended.

(d) Behavior analysts do not barter for services, unless a written agreement is in place for the barter that is (1) requested by the client or supervisee; (2) customary to the area where services are provided; and (3) fair and commensurate with the value of behavior-analytic services provided.

2.0 Behavior Analysts’ Responsibility to Clients.

Behavior analysts have a responsibility to operate in the best interest of clients. The term client as used here is broadly applicable to whomever behavior analysts provide services, whether an individual person (service recipient), a parent or guardian of a service recipient, an organizational representative, a public or private organization, a firm, or a corporation.

2.01 Accepting Clients.

Behavior analysts accept as clients only those individuals or entities whose requested services are commensurate with the behavior analysts’ education, training, experience, available resources, and organizational policies. In lieu of these conditions, behavior analysts must function under the supervision of or in consultation with a behavior analyst whose credentials permit performing such services.

2.02 Responsibility.

Behavior analysts’ responsibility is to all parties affected by behavior-analytic services. When multiple parties are involved and could be defined as a client, a hierarchy of parties must be established and communicated from the outset of the defined relationship. Behavior analysts identify and communicate who the primary ultimate beneficiary of services is in any given situation and advocate for his or her best interests.

2.03 Consultation.

(a) Behavior analysts arrange for appropriate consultations and referrals based principally on the best interests of their clients, with appropriate consent, and subject to other relevant considerations, including applicable law and contractual obligations.

(b) When indicated and professionally appropriate, behavior analysts cooperate with other professionals, in a manner that is consistent with the philosophical assumptions and principles of behavior analysis, in order to effectively and appropriately serve their clients.

 

 

7

=

=

®

2.04 Third-Party Involvement in Services.

(a) When behavior analysts agree to provide services to a person or entity at the request of a third party, behavior analysts clarify, to the extent feasible and at the outset of the service, the nature of the relationship with each party and any potential conflicts. This clarification includes the role of the behavior analyst (such as therapist, organizational consultant, or expert witness), the probable uses of the services provided or the information obtained, and the fact that there may be limits to confidentiality.

(b) If there is a foreseeable risk of behavior analysts being called upon to perform conflicting roles because of the involvement of a third party, behavior analysts clarify the nature and direction of their responsibilities, keep all parties appropriately informed as matters develop, and resolve the situation in accordance with this Code.

(c) When providing services to a minor or individual who is a member of a protected population at the request of a third party, behavior analysts ensure that the parent or client-surrogate of the ultimate recipient of services is informed of the nature and scope of services to be provided, as well as their right to all service records and data.

(d) Behavior analysts put the client’s care above all others and, should the third party make requirements for services that are contraindicated by the behavior analyst’s recommendations, behavior analysts are obligated to resolve such conflicts in the best interest of the client. If said conflict cannot be resolved, that behavior analyst’s services to the client may be discontinued following appropriate transition.

2.05 Rights and Prerogatives of Clients.

(a) The rights of the client are paramount and behavior analysts support clients’ legal rights and prerogatives.

(b) Clients and supervisees must be provided, on request, an accurate and current set of the behavior analyst’s credentials.

(c) Permission for electronic recording of interviews and service delivery sessions is secured from clients and relevant staff in all relevant settings. Consent for different uses must be obtained specifically and separately.

(d) Clients and supervisees must be informed of their rights and about procedures to lodge complaints about professional practices of behavior analysts with the employer, appropriate authorities, and the BACB.

(e) Behavior analysts comply with any requirements for criminal background checks.

2.06 Maintaining Confidentiality.

(a) Behavior analysts have a primary obligation and take reasonable precautions to protect the confidentiality of those with whom they work or consult, recognizing that confidentiality may be established by law, organizational rules, or professional or scientific relationships.

 

 

8

=

=

®

(b) Behavior analysts discuss confidentiality at the outset of the relationship and thereafter as new circumstances may warrant.

(c) In order to minimize intrusions on privacy, behavior analysts include only information germane to the purpose for which the communication is made in written, oral, and electronic reports, consultations, and other avenues.

(d) Behavior analysts discuss confidential information obtained in clinical or consulting relationships, or evaluative data concerning clients, students, research participants, supervisees, and employees, only for appropriate scientific or professional purposes and only with persons clearly concerned with such matters.

(e) Behavior analysts must not share or create situations likely to result in the sharing of any identifying information (written, photographic, or video) about current clients and supervisees within social media contexts.

2.07 Maintaining Records.

(a) Behavior analysts maintain appropriate confidentiality in creating, storing, accessing, transferring, and disposing of records under their control, whether these are written, automated, electronic, or in any other medium.

(b) Behavior analysts maintain and dispose of records in accordance with applicable laws, regulations, corporate policies, and organizational policies, and in a manner that permits compliance with the requirements of this Code.

2.08 Disclosures.

Behavior analysts never disclose confidential information without the consent of the client, except as mandated by law, or where permitted by law for a valid purpose, such as (1) to provide needed professional services to the client, (2) to obtain appropriate professional consultations, (3) to protect the client or others from harm, or (4) to obtain payment for services, in which instance disclosure is limited to the minimum that is necessary to achieve the purpose. Behavior analysts recognize that parameters of consent for disclosure should be acquired at the outset of any defined relationship and is an ongoing procedure throughout the duration of the professional relationship.

2.09 Treatment/Intervention Efficacy.

(a) Clients have a right to effective treatment (i.e., based on the research literature and adapted to the individual client). Behavior analysts always have the obligation to advocate for and educate the client about scientifically supported, most-effective treatment procedures. Effective treatment procedures have been validated as having both long-term and short-term benefits to clients and society.

(b) Behavior analysts have the responsibility to advocate for the appropriate amount and level of

 

 

9

=

=

®

service provision and oversight required to meet the defined behavior-change program goals. (c) In those instances where more than one scientifically supported treatment has been established,

additional factors may be considered in selecting interventions, including, but not limited to, efficiency and cost-effectiveness, risks and side-effects of the interventions, client preference, and practitioner experience and training.

(d) Behavior analysts review and appraise the effects of any treatments about which they are aware that might impact the goals of the behavior-change program, and their possible impact on the behavior- change program, to the extent possible.

2.10 Documenting Professional Work and Research.

(a) Behavior analysts appropriately document their professional work in order to facilitate provision of services later by them or by other professionals, to ensure accountability, and to meet other requirements of organizations or the law.

(b) Behavior analysts have a responsibility to create and maintain documentation in the kind of detail and quality that would be consistent with best practices and the law.

2.11 Records and Data.

(a) Behavior analysts create, maintain, disseminate, store, retain, and dispose of records and data relating to their research, practice, and other work in accordance with applicable laws, regulations, and policies; in a manner that permits compliance with the requirements of this Code; and in a manner that allows for appropriate transition of service oversight at any moment in time.

(b) Behavior analysts must retain records and data for at least seven (7) years and as otherwise required by law.

2.12 Contracts, Fees, and Financial Arrangements.

(a) Prior to the implementation of services, behavior analysts ensure that there is in place a signed contract outlining the responsibilities of all parties, the scope of behavior-analytic services to be provided, and behavior analysts’ obligations under this Code.

(b) As early as is feasible in a professional or scientific relationship, behavior analysts reach an agreement with their clients specifying compensation and billing arrangements.

(c) Behavior analysts’ fee practices are consistent with law and behavior analysts do not misrepresent their fees. If limitations to services can be anticipated because of limitations in funding, this is discussed with the client as early as is feasible.

(d) When funding circumstances change, the financial responsibilities and limits must be revisited with the client.

 

 

10

=

=

®

2.13 Accuracy in Billing Reports.

Behavior analysts accurately state the nature of the services provided, the fees or charges, the identity of the provider, relevant outcomes, and other required descriptive data.

2.14 Referrals and Fees.

Behavior analysts must not receive or provide money, gifts, or other enticements for any professional referrals. Referrals should include multiple options and be made based on objective determination of the client need and subsequent alignment with the repertoire of the referee. When providing or receiving a referral, the extent of any relationship between the two parties is disclosed to the client.

2.15 Interrupting or Discontinuing Services.

(a) Behavior analysts act in the best interests of the client and supervisee to avoid interruption or disruption of service.

(b) Behavior analysts make reasonable and timely efforts for facilitating the continuation of behavior- analytic services in the event of unplanned interruptions (e.g., due to illness, impairment, unavailability, relocation, disruption of funding, disaster).

(c) When entering into employment or contractual relationships, behavior analysts provide for orderly and appropriate resolution of responsibility for services in the event that the employment or contractual relationship ends, with paramount consideration given to the welfare of the ultimate beneficiary of services.

(d) Discontinuation only occurs after efforts to transition have been made. Behavior analysts discontinue a professional relationship in a timely manner when the client: (1) no longer needs the service, (2) is not benefiting from the service, (3) is being harmed by continued service, or (4) when the client requests discontinuation. (See also, 4.11 Discontinuing Behavior-Change Programs and Behavior-Analytic Services)

(e) Behavior analysts do not abandon clients and supervisees. Prior to discontinuation, for whatever reason, behavior analysts: discuss service needs, provide appropriate pre-termination services, suggest alternative service providers as appropriate, and, upon consent, take other reasonable steps

to facilitate timely transfer of responsibility to another provider.

3.0 Assessing Behavior.

Behavior analysts using behavior-analytic assessment techniques do so for purposes that are appropriate given current research.

 

 

11

=

=

®

3.01 Behavior-Analytic Assessment.

(a) Behavior analysts conduct current assessments prior to making recommendations or developing behavior-change programs. The type of assessment used is determined by client’s needs and consent, environmental parameters, and other contextual variables. When behavior analysts are developing a behavior-reduction program, they must first conduct a functional assessment.

(b) Behavior analysts have an obligation to collect and graphically display data, using behavior-analytic conventions, in a manner that allows for decisions and recommendations for behavior-change program development.

3.02 Medical Consultation.

Behavior analysts recommend seeking a medical consultation if there is any reasonable possibility that a referred behavior is influenced by medical or biological variables.

3.03 Behavior-Analytic Assessment Consent.

(a) Prior to conducting an assessment, behavior analysts must explain to the client the procedure(s) to be used, who will participate, and how the resulting information will be used.

(b) Behavior analysts must obtain the client’s written approval of the assessment procedures before implementing them.

3.04 Explaining Assessment Results.

Behavior analysts explain assessment results using language and graphic displays of data that are reasonably understandable to the client.

3.05 Consent-Client Records.

Behavior analysts obtain the written consent of the client before obtaining or disclosing client records from or to other sources, for assessment purposes.

4.0 Behavior Analysts and the Behavior-Change Program. Behavior analysts are responsible for all aspects of the behavior-change program from conceptualization to implementation and ultimately to discontinuation.

 

 

12

=

=

®

4.01 Conceptual Consistency.

Behavior analysts design behavior-change programs that are conceptually consistent with behavior- analytic principles.

4.02 Involving Clients in Planning and Consent.

Behavior analysts involve the client in the planning of and consent for behavior-change programs.

4.03 Individualized Behavior-Change Programs.

(a) Behavior analysts must tailor behavior-change programs to the unique behaviors, environmental variables, assessment results, and goals of each client.

(b) Behavior analysts do not plagiarize other professionals’ behavior-change programs.

4.04 Approving Behavior-Change Programs.

Behavior analysts must obtain the client’s written approval of the behavior-change program before implementation or making significant modifications (e.g., change in goals, use of new procedures).

4.05 Describing Behavior-Change Program Objectives.

Behavior analysts describe, in writing, the objectives of the behavior-change program to the client before attempting to implement the program. To the extent possible, a risk-benefit analysis should be conducted on the procedures to be implemented to reach the objective. The description of program objectives and the means by which they will be accomplished is an ongoing process throughout the duration of the client-practitioner relationship.

4.06 Describing Conditions for Behavior-Change Program Success.

Behavior analysts describe to the client the environmental conditions that are necessary for the behavior-change program to be effective.

4.07 Environmental Conditions that Interfere with Implementation.

(a) If environmental conditions prevent implementation of a behavior-change program, behavior analysts recommend that other professional assistance (e.g., assessment, consultation or therapeutic intervention by other professionals) be sought.

(b) If environmental conditions hinder implementation of the behavior-change program, behavior analysts seek to eliminate the environmental constraints, or identify in writing the obstacles to doing so.

 

 

13

=

=

®

4.08 Considerations Regarding Punishment Procedures.

(a) Behavior analysts recommend reinforcement rather than punishment whenever possible. (b) If punishment procedures are necessary, behavior analysts always include reinforcement procedures

for alternative behavior in the behavior-change program. (c) Before implementing punishment-based procedures, behavior analysts ensure that appropriate

steps have been taken to implement reinforcement-based procedures unless the severity or dangerousness of the behavior necessitates immediate use of aversive procedures.

(d) Behavior analysts ensure that aversive procedures are accompanied by an increased level of training, supervision, and oversight. Behavior analysts must evaluate the effectiveness of aversive procedures in a timely manner and modify the behavior-change program if it is ineffective. Behavior analysts always include a plan to discontinue the use of aversive procedures when no longer needed.

4.09 Least Restrictive Procedures.

Behavior analysts review and appraise the restrictiveness of procedures and always recommend the least restrictive procedures likely to be effective.

4.10 Avoiding Harmful Reinforcers. Behavior analysts minimize the use of items as potential reinforcers that may be harmful to the health

and development of the client, or that may require excessive motivating operations to be effective.

4.11 Discontinuing Behavior-Change Programs and Behavior-Analytic Services.

(a) Behavior analysts establish understandable and objective (i.e., measurable) criteria for the discontinuation of the behavior change program and describe them to the client. (See also, 2.15d Interrupting or Discontinuing Services)

(b) Behavior analysts discontinue services with the client when the established criteria for discontinuation are attained, as in when a series of agreed-upon goals have been met. (See also, 2.15d Interrupting or Discontinuing Services)

5.0 Behavior Analysts as Supervisors.

When behavior analysts are functioning as supervisors, they must take full responsibility for all facets of this undertaking. (See also, 1.06 Multiple Relationships and Conflict of Interest, 1.07 Exploitative Relationships, 2.05 Rights and Prerogatives of Clients, 2.06 Maintaining Confidentiality, 2.15 Interrupting or Discontinuing Services, 8.04 Media Presentations and Media-Based Services, 9.02 Characteristics of Responsible Research, 10.05 Compliance with BACB Supervision and Coursework Standards)

 

 

14

=

=

®

5.01 Supervisory Competence.

Behavior analysts supervise only within their areas of defined competence.

5.02 Supervisory Volume.

Behavior analysts take on only a volume of supervisory activity that is commensurate with their ability to be effective.

5.03 Supervisory Delegation.

a) Behavior analysts delegate to their supervisees only those responsibilities that such persons can reasonably be expected to perform competently, ethically, and safely.

b) If the supervisee does not have the skills necessary to perform competently, ethically, and safely, behavior analysts provide conditions for the acquisition of those skills.

5.04 Designing Effective Supervision and Training.

Behavior analysts ensure that supervision and trainings are behavior-analytic in content, effectively and ethically designed, and meet the requirements for licensure, certification, or other defined goals.

5.05 Communication of Supervision Conditions.

Behavior analysts provide a clear written description of the purpose, requirements, evaluation criteria, conditions, and terms of supervision prior to the onset of the supervision.

5.06 Providing Feedback to Supervisees. a) Behavior analysts design feedback and reinforcement systems in a way that improves supervisee

performance. b) Behavior analysts provide documented, timely feedback regarding the performance of a supervisee

on an ongoing basis. (See also, 10.05 Compliance with BACB Supervision and Coursework Standards)

5.07 Evaluating the Effects of Supervision.

Behavior analysts design systems for obtaining ongoing evaluation of their own supervision activities.

6.0 Behavior Analysts’ Ethical Responsibility to the Profession of Behavior Analysis.

Behavior analysts have an obligation to the science of behavior and profession of behavior analysis.

 

 

15

=

=

®

6.01 Affirming Principles.

a) Above all other professional training, behavior analysts uphold and advance the values, ethics, and principles of the profession of behavior analysis.

b) Behavior analysts have an obligation to participate in behavior-analytic professional and scientific organizations or activities.

6.02 Disseminating Behavior Analysis.

Behavior analysts promote behavior analysis by making information about it available to the public through presentations, discussions, and other media.

7.0 Behavior Analysts’ Ethical Responsibility to Colleagues.

Behavior analysts work with colleagues within the profession of behavior analysis and from other professions and must be aware of these ethical obligations in all situations. (See also, 10.0 Behavior Analysts’ Ethical Responsibility to the BACB)

7.01 Promoting an Ethical Culture.

Behavior analysts promote an ethical culture in their work environments and make others aware of this Code.

7.02 Ethical Violations by Others and Risk of Harm.

(a) If behavior analysts believe there may be a legal or ethical violation, they first determine whether there is potential for harm, a possible legal violation, a mandatory-reporting condition, or an agency, organization, or regulatory requirement addressing the violation.

(b) If a client’s legal rights are being violated, or if there is the potential for harm, behavior analysts must take the necessary action to protect the client, including, but not limited to, contacting relevant authorities, following organizational policies, and consulting with appropriate professionals, and documenting their efforts to address the matter.

(c) If an informal resolution appears appropriate, and would not violate any confidentiality rights, behavior analysts attempt to resolve the issue by bringing it to the attention of that individual and documenting their efforts to address the matter. If the matter is not resolved, behavior analysts report the matter to the appropriate authority (e.g., employer, supervisor, regulatory authority).

(d) If the matter meets the reporting requirements of the BACB, behavior analysts submit a formal complaint to the BACB. (See also, 10.02 Timely Responding, Reporting, and Updating of Information Provided to the BACB)

 

 

16

=

=

®

8.0 Public Statements.

Behavior analysts comply with this Code in public statements relating to their professional services, products, or publications, or to the profession of behavior analysis. Public statements include, but are not limited to, paid or unpaid advertising, brochures, printed matter, directory listings, personal resumes or curriculum vitae, interviews or comments for use in media, statements in legal proceedings, lectures and public presentations, social media, and published materials.

8.01 Avoiding False or Deceptive Statements.

(a) Behavior analysts do not make public statements that are false, deceptive, misleading, exaggerated, or fraudulent, either because of what they state, convey, or suggest or because of what they omit, concerning their research, practice, or other work activities or those of persons or organizations with which they are affiliated. Behavior analysts claim as credentials for their behavior-analytic work, only degrees that were primarily or exclusively behavior-analytic in content.

(b) Behavior analysts do not implement non-behavior-analytic interventions. Non-behavior-analytic services may only be provided within the context of non-behavior-analytic education, formal training, and credentialing. Such services must be clearly distinguished from their behavior-analytic practices and BACB certification by using the following disclaimer: “These interventions are not behavior-analytic in nature and are not covered by my BACB credential.” The disclaimer should be placed alongside the names and descriptions of all non-behavior-analytic interventions.

(c) Behavior analysts do not advertise non-behavior-analytic services as being behavior-analytic. (d) Behavior analysts do not identify non-behavior-analytic services as behavior-analytic services on

bills, invoices, or requests for reimbursement. (e) Behavior analysts do not implement non-behavior-analytic services under behavior-analytic service

authorizations.

8.02 Intellectual Property.

(a) Behavior analysts obtain permission to use trademarked or copyrighted materials as required by law. This includes providing citations, including trademark or copyright symbols on materials, that recognize the intellectual property of others.

(b) Behavior analysts give appropriate credit to authors when delivering lectures, workshops, or other presentations.

8.03 Statements by Others.

(a) Behavior analysts who engage others to create or place public statements that promote their professional practice, products, or activities retain professional responsibility for such statements.

(b) Behavior analysts make reasonable efforts to prevent others whom they do not oversee (e.g.,

 

 

17

=

=

®

employers, publishers, sponsors, organizational clients, and representatives of the print or broadcast media) from making deceptive statements concerning behavior analysts’ practices or professional or scientific activities.

(c) If behavior analysts learn of deceptive statements about their work made by others, behavior analysts correct such statements.

(d) A paid advertisement relating to behavior analysts’ activities must be identified as such, unless it is apparent from the context.

8.04 Media Presentations and Media-Based Services.

(a) Behavior analysts using electronic media (e.g., video, e-learning, social media, electronic transmission of information) obtain and maintain knowledge regarding the security and limitations of electronic media in order to adhere to this Code.

(b) Behavior analysts making public statements or delivering presentations using electronic media do not disclose personally identifiable information concerning their clients, supervisees, students, research participants, or other recipients of their services that they obtained during the course of their work, unless written consent has been obtained.

(c) Behavior analysts delivering presentations using electronic media disguise confidential information concerning participants, whenever possible, so that they are not individually identifiable to others and so that discussions do not cause harm to identifiable participants.

(d) When behavior analysts provide public statements, advice, or comments by means of public lectures, demonstrations, radio or television programs, electronic media, articles, mailed material, or other media, they take reasonable precautions to ensure that (1) the statements are based on appropriate behavior-analytic literature and practice, (2) the statements are otherwise consistent with this Code, and (3) the advice or comment does not create an agreement for service with the recipient.

8.05 Testimonials and Advertising.

Behavior analysts do not solicit or use testimonials about behavior-analytic services from current clients for publication on their webpages or in any other electronic or print material. Testimonials from former clients must identify whether they were solicited or unsolicited, include an accurate statement of the relationship between the behavior analyst and the author of the testimonial, and comply with all applicable laws about claims made in the testimonial.

Behavior analysts may advertise by describing the kinds and types of evidence-based services they provide, the qualifications of their staff, and objective outcome data they have accrued or published, in accordance with applicable laws.

 

 

18

=

=

®

8.06 In-Person Solicitation.

Behavior analysts do not engage, directly or through agents, in uninvited in-person solicitation of business from actual or potential users of services who, because of their particular circumstances, are vulnerable to undue influence. Organizational behavior management or performance management services may be marketed to corporate entities regardless of their projected financial position.

9.0 Behavior Analysts and Research.

Behavior analysts design, conduct, and report research in accordance with recognized standards of scientific competence and ethical research.

9.01 Conforming with Laws and Regulations.

Behavior analysts plan and conduct research in a manner consistent with all applicable laws and regulations, as well as professional standards governing the conduct of research. Behavior analysts also comply with other applicable laws and regulations relating to mandated-reporting requirements.

9.02 Characteristics of Responsible Research.

(a) Behavior analysts conduct research only after approval by an independent, formal research review board.

(b) Behavior analysts conducting applied research conjointly with provision of clinical or human services must comply with requirements for both intervention and research involvement by client- participants. When research and clinical needs conflict, behavior analysts prioritize the welfare of the client.

(c) Behavior analysts conduct research competently and with due concern for the dignity and welfare of the participants.

(d) Behavior analysts plan their research so as to minimize the possibility that results will be misleading. (e) Researchers and assistants are permitted to perform only those tasks for which they are

appropriately trained and prepared. Behavior analysts are responsible for the ethical conduct of research conducted by assistants or by others under their supervision or oversight.

(f) If an ethical issue is unclear, behavior analysts seek to resolve the issue through consultation with independent, formal research review boards, peer consultations, or other proper mechanisms.

(g) Behavior analysts only conduct research independently after they have successfully conducted research under a supervisor in a defined relationship (e.g., thesis, dissertation, specific research project).

(h) Behavior analysts conducting research take necessary steps to maximize benefit and minimize risk to their clients, supervisees, research participants, students, and others with whom they work.

(i) Behavior analysts minimize the effect of personal, financial, social, organizational, or political factors

 

 

19

=

=

®

that might lead to misuse of their research. (j) If behavior analysts learn of misuse or misrepresentation of their individual work products, they

take appropriate steps to correct the misuse or misrepresentation. (k) Behavior analysts avoid conflicts of interest when conducting research. (l) Behavior analysts minimize interference with the participants or environment in which research is

conducted.

9.03 Informed Consent.

Behavior analysts inform participants or their guardian or surrogate in understandable language about the nature of the research; that they are free to participate, to decline to participate, or to withdraw from the research at any time without penalty; about significant factors that may influence their willingness to participate; and answer any other questions participants may have about the research.

9.04 Using Confidential Information for Didactic or Instructive Purposes.

(a) Behavior analysts do not disclose personally identifiable information concerning their individual or organizational clients, research participants, or other recipients of their services that they obtained during the course of their work, unless the person or organization has consented in writing or unless there is other legal authorization for doing so.

(b) Behavior analysts disguise confidential information concerning participants, whenever possible, so that they are not individually identifiable to others and so that discussions do not cause harm to identifiable participants.

9.05 Debriefing.

Behavior analysts inform the participant that debriefing will occur at the conclusion of the participant’s involvement in the research.

9.06 Grant and Journal Reviews.

Behavior analysts who serve on grant review panels or as manuscript reviewers avoid conducting any research described in grant proposals or manuscripts that they reviewed, except as replications fully crediting the prior researchers.

9.07 Plagiarism.

(a) Behavior analysts fully cite the work of others where appropriate. (b) Behavior analysts do not present portions or elements of another’s work or data as their own.

 

 

20

=

=

®

9.08 Acknowledging Contributions.

Behavior analysts acknowledge the contributions of others to research by including them as co-authors or footnoting their contributions. Principal authorship and other publication credits accurately reflect the relative scientific or professional contributions of the individuals involved, regardless of their relative status. Minor contributions to the research or to the writing for publications are appropriately acknowledged, such as, in a footnote or introductory statement.

9.09 Accuracy and Use of Data.

(a) Behavior analysts do not fabricate data or falsify results in their publications. If behavior analysts discover errors in their published data, they take steps to correct such errors in a correction, retraction, erratum, or other appropriate publication means.

(b) Behavior analysts do not omit findings that might alter interpretations of their work. (c) Behavior analysts do not publish, as original data, data that have been previously published. This does

not preclude republishing data when they are accompanied by proper acknowledgment. (d) After research results are published, behavior analysts do not withhold the data on which their

conclusions are based from other competent professionals who seek to verify the substantive claims through reanalysis and who intend to use such data only for that purpose, provided that the confidentiality of the participants can be protected and unless legal rights concerning proprietary data preclude their release.

10.0 Behavior Analysts’ Ethical Responsibility to the BACB.

Behavior analysts must adhere to this Code and all rules and standards of the BACB.

10.01 Truthful and Accurate Information Provided to the BACB.

(a) Behavior analysts only provide truthful and accurate information in applications and documentation submitted to the BACB.

(b) Behavior analysts ensure that inaccurate information submitted to the BACB is immediately corrected.

10.02 Timely Responding, Reporting, and Updating of Information Provided to the BACB.

Behavior analysts must comply with all BACB deadlines including, but not limited to, ensuring that the BACB is notified within thirty (30) days of the date of any of the following grounds for sanctioning status: (a) A violation of this Code, or disciplinary investigation, action or sanction, filing of charges, conviction

or plea of guilty or no contest (i.e., nolo contendere) by a governmental agency, health care organization, third-party payer or educational institution. Procedural note: Behavior analysts convicted of a felony directly related to behavior analysis practice and/or public health and safety

 

 

21

=

=

®

shall be ineligible to apply for BACB registration, certification, or recertification for a period of three (3) years from the exhaustion of appeals, completion of parole or probation, or final release from confinement (if any), whichever is later; (See also, 1.04d Integrity)

(b) Any public health- and safety-related fines or tickets where the behavior analyst is named on the ticket;

(c) A physical or mental condition that would impair the behavior analysts’ ability to competently practice; and

(d) A change of name, address or email contact.

10.03 Confidentiality and BACB Intellectual Property.

Behavior analysts do not infringe on the BACB’s intellectual property rights, including, but not limited to the BACB’s rights to the following: (a) BACB logo, VCS logo, ACE logo, certificates, credentials and designations, including, but not

limited to, trademarks, service marks, registration marks and certification marks owned and claimed by the BACB (this includes confusingly similar marks intended to convey BACB affiliation, certification or registration, or misrepresentation of an educational ABA certificate status as constituting national certification);

(b) BACB copyrights to original and derivative works, including, but not limited to, BACB copyrights to standards, procedures, guidelines, codes, job task analysis, Workgroup reports, surveys; and

(c) BACB copyrights to all BACB-developed examination questions, item banks, examination specifications, examination forms and examination scoring sheets, which are secure trade secrets of the BACB. Behavior analysts are expressly prohibited from disclosing the content of any BACB examination materials, regardless of how that content became known to them. Behavior analysts report suspected or known infringements and/or unauthorized access to examination content and/ or any other violation of BACB intellectual property rights immediately to the BACB. Efforts for informal resolution (identified in Section 7.02 c) are waived due to the immediate reporting requirement of this Section.

10.04 Examination Honesty and Irregularities.

Behavior analysts adhere to all rules of the BACB, including the rules and procedures required by BACB approved testing centers and examination administrators and proctors. Behavior analysts must immediately report suspected cheaters and any other irregularities relating to the BACB examination administrations to the BACB. Examination irregularities include, but are not limited to, unauthorized access to BACB examinations or answer sheets, copying answers, permitting another to copy answers, disrupting the conduct of an examination, falsifying information, education or credentials, and providing and/or receiving unauthorized or illegal advice about or access to BACB examination content before, during, or following the examination. This prohibition includes, but is not limited to, use of or participation in any “exam dump” preparation site or blog that provides unauthorized

 

 

22

=

=

®

access to BACB examination questions. If, at any time, it is discovered that an applicant or certificant has participated in or utilized an exam dump organization, immediate action may be taken to withdraw eligibility, cancel examination scores, or otherwise revoke certification gained through use of inappropriately obtained examination content.

10.05 Compliance with BACB Supervision and Coursework Standards.

Behavior analysts ensure that coursework (including continuing education events), supervised experience, RBT training and assessment, and BCaBA supervision are conducted in accordance with the BACB’s standards if these activities are intended to comply with BACB standards (See also, 5.0 Behavior Analysts as Supervisors)

10.06 Being Familiar with This Code.

Behavior analysts have an obligation to be familiar with this Code, other applicable ethics codes, including, but not limited to, licensure requirements for ethical conduct, and their application to behavior analysts’ work. Lack of awareness or misunderstanding of a conduct standard is not itself a defense to a charge of unethical conduct.

10.07 Discouraging Misrepresentation by Non-Certified Individuals.

Behavior analysts report non-certified (and, if applicable, non-registered) practitioners to the appropriate state licensing board and to the BACB if the practitioners are misrepresenting BACB certification or registration status.

 

 

23

=

=

®

Glossary

Behavior Analyst Behavior analyst refers to an individual who holds BCBA or BCaBA certification or an individual who has submitted a complete application for BCBA or BCaBA certification.

Behavior-Analytic Services Behavior-analytic services are those that are explicitly based on principles and procedures of behavior analysis (i.e., the science of behavior) and are designed to change behavior in socially important ways. These services include, but are not limited to, treatment, assessment, training, consultation, managing and supervising others, teaching, and delivering continuing education.

Behavior-Change Program The behavior-change program is a formal, written document that describes in technological detail every assessment and treatment task necessary to achieve stated goals.

Client The term client refers to any recipient or beneficiary of the professional services provided by a behavior analyst. The term includes, but is not limited to:

(a) The direct recipient of services; (b) The parent, relative, legal representative or legal guardian of the recipient of services; (c) The employer, agency representative, institutional representative, or third-party contractor for

services of the behavior analyst; and/or (d) Any other individual or entity that is a known beneficiary of services or who would normally be

construed as a “client” or “client-surrogate”.

For purposes of this definition, the term client does not include third-party insurers or payers, unless the behavior analyst is hired directly under contract with the third-party insurer or payer.

Functional Assessment Functional assessment, also known as functional behavior assessment, refers to a category of procedures used to formally assess the possible environmental causes of problem behavior. These procedures include informant assessments (e.g., interviews, rating scales), direct observation in the natural environment (e.g., ABC assessment), and experimental functional analysis.

Multiple Relationships A multiple relationship is one in which a behavior analyst is in both a behavior-analytic role and a non- behavior-analytic role simultaneously with a client, supervisee, or someone closely associated with or related to the client.

 

 

24

=

=

®

Public Statements Public statements include, but are not limited to, paid or unpaid advertising, brochures, printed matter, directory listings, personal resumes or curriculum vitae, interviews or comments for use in media, statements in legal proceedings, lectures and public presentations, social media, and published materials.

Research Any data-based activity designed to generate generalizable knowledge for the discipline, often through professional presentations or publications. The use of an experimental design does not by itself constitute research. Professional presentation or publication of already collected data are exempt from elements in section 9.0 (Behavior Analysts and Research) that pertain to prospective research activities (e.g., 9.02a). However, all remaining relevant elements from section 9.0 apply (e.g., 9.01 Conforming with Laws and Regulations; 9.03 Informed Consent relating to use of client data).

Research Review Board A group of professionals whose stated purpose is to review research proposals to ensure the ethical treatment of human research participants. This board might be an official entity of a government or university (e.g., Institutional Review Board, Human Research Committee), a standing committee within a service agency, or an independent organization created for this purpose.

Rights and Prerogatives of Clients Rights and prerogatives of clients refers to human rights, legal rights, rights codified within behavior analysis, and organizational and administrative rules and regulations designed to benefit the client.

Risk-Benefit Analysis A risk-benefit analysis is a deliberate evaluation of the potential risks (e.g., limitations, side effects, costs) and benefits (e.g., treatment outcomes, efficiency, savings) associated with a given intervention. A risk-benefit analysis should conclude with a course of action associated with greater benefits than risks.

Service Record A client’s service record includes, but is not limited to, written behavior-change plans, assessments, graphs, raw data, electronic recordings, progress summaries, and written reports.

Student A student is an individual who is matriculated at a college/university. This Code applies to the student during formal behavior-analytic instruction.

Supervisee A supervisee is any individual whose behavior-analytic services are overseen by a behavior analyst within the context of a defined, agreed-upon relationship.

Copyright © 2014 by the Behavior Analyst Certification Board,® Inc. (“BACB®”). Electronic and/or paper copies of part or all of this work may be made for personal, educational, or policymaking purposes, provided such copies are not made or distributed for profit or commercial advantage. All copies, unless made for regulatory or licensure purposes, must include this notice on the first page. Abstracting with proper credit is permitted, so long as the credit reads “Copyright © 2014 by the Behavior Analyst Certification Board,® Inc. (“BACB®”), all rights reserved.” All other uses and/or distributions in any medium require advance written permission of the BACB. To request permission complete the Copyright and/or Trademark Permission Request form.

CASE STUDY 4: Focused Thyroid Exam

CASE STUDY 4: Focused Thyroid Exam

Chantal, a 32-year-old female, comes into your office with complaints of “feeling tired” and “hair falling out”.  She has gained 30 pounds in the last year but notes markedly decreased appetite. On ROS, she reports not sleeping well and feels cold all the time. She is still able to enjoy her hobbies and does not believe that she is depressed

Case Study Assignment should be in the Episodic/Focused SOAP Note format rather than the traditional narrative style format .

 

  • Consider what history would be necessary to collect from the patient.
  • Consider what physical exams and diagnostic tests would be appropriate to gather more information about the patient’s condition. How would the results be used to make a diagnosis?
  • Identify at least five possible conditions that may be considered in a differential diagnosis for the patient.

 

Episodic/Focused SOAP Note Template

Patient Information:

Initials, Age, Sex, Race

S.

CC (chief complaint) a BRIEF statement identifying why the patient is here – in the patient’s own words – for instance “headache”, NOT “bad headache for 3 days”.

HPI: This is the symptom analysis section of your note. Thorough documentation in this section is essential for patient care, coding, and billing analysis. Paint a picture of what is wrong with the patient. Use LOCATES Mnemonic to complete your HPI. You need to start EVERY HPI with age, race, and gender (e.g., 34-year-old AA male). You must include the seven attributes of each principal symptom in paragraph form not a list. If the CC was “headache”, the LOCATES for the HPI might look like the following example:

Location: head

Onset: 3 days ago

Character: pounding, pressure around the eyes and temples

Associated signs and symptoms: nausea, vomiting, photophobia, phonophobia

Timing: after being on the computer all day at work

Exacerbating/ relieving factors: light bothers eyes, Aleve makes it tolerable but not completely better

Severity: 7/10 pain scale

Current Medications: include dosage, frequency, length of time used and reason for use; also include OTC or homeopathic products.

Allergies: include medication, food, and environmental allergies separately (a description of what the allergy is ie angioedema, anaphylaxis, etc. This will help determine a true reaction vs intolerance).

PMHx: include immunization status (note date of last tetanus for all adults), past major illnesses and surgeries. Depending on the CC, more info is sometimes needed
Soc Hx: include occupation and major hobbies, family status, tobacco & alcohol use (previous and current use), any other pertinent data. Always add some health promo question here – such as whether they use seat belts all the time or whether they have working smoke detectors in the house, living environment, text/cell phone use while driving, and support system.

Fam Hx: illnesses with possible genetic predisposition, contagious or chronic illnesses. Reason for death of any deceased first degree relatives should be included. Include parents, grandparents, siblings, and children. Include grandchildren if pertinent.

ROS: cover all body systems that may help you include or rule out a differential diagnosis You should list each system as follows: General: HeadEENT: etc. You should list these in bullet format and document the systems in order from head to toe.

Example of Complete ROS:

GENERAL:  No weight loss, fever, chills, weakness or fatigue.

HEENT:  Eyes:  No visual loss, blurred vision, double vision or yellow sclerae. Ears, Nose, Throat:  No hearing loss, sneezing, congestion, runny nose or sore throat.

SKIN:  No rash or itching.

CARDIOVASCULAR:  No chest pain, chest pressure or chest discomfort. No palpitations or edema.

RESPIRATORY:  No shortness of breath, cough or sputum.

GASTROINTESTINAL:  No anorexia, nausea, vomiting or diarrhea. No abdominal pain or blood.

GENITOURINARY:  Burning on urination. Pregnancy. Last menstrual period, MM/DD/YYYY.

NEUROLOGICAL:  No headache, dizziness, syncope, paralysis, ataxia, numbness or tingling in the extremities. No change in bowel or bladder control.

MUSCULOSKELETAL:  No muscle, back pain, joint pain or stiffness.

HEMATOLOGIC:  No anemia, bleeding or bruising.

LYMPHATICS:  No enlarged nodes. No history of splenectomy.

PSYCHIATRIC:  No history of depression or anxiety.

ENDOCRINOLOGIC:  No reports of sweating, cold or heat intolerance. No polyuria or polydipsia.

ALLERGIES:  No history of asthma, hives, eczema or rhinitis.

O.

Physical exam: From head-to-toe, include what you see, hear, and feel when doing your physical exam. You only need to examine the systems that are pertinent to the CC, HPI, and History. Do not use “WNL” or “normal.” You must describe what you see. Always document in head to toe format i.e. General: Head: EENT: etc.

Diagnostic results: Include any labs, x-rays, or other diagnostics that are needed to develop the differential diagnoses (support with evidenced and guidelines)

A.

Differential Diagnoses (list a minimum of 3 differential diagnoses).Your primary or presumptive diagnosis should be at the top of the list. For each diagnosis, provide supportive documentation with evidence based guidelines.

P.

This section is not required for the assignments in this course (NURS 6512) but will be required for future courses.

References

You are required to include at least three evidence based peer-reviewed journal articles or evidenced based guidelines which relates to this case to support your diagnostics and differentials diagnoses. Be sure to use correct APA 6th edition formatting.

Episodic/Focused SOAP Note Template

 

Patient Information:

Initials, Age, Sex, Race

S.

CC (chief complaint) a BRIEF statement identifying why the patient is here – in the patient’s own words – for instance “headache”, NOT “bad headache for 3 days”.

HPI: This is the symptom analysis section of your note. Thorough documentation in this section is essential for patient care, coding, and billing analysis. Paint a picture of what is wrong with the patient. Use LOCATES Mnemonic to complete your HPI. You need to start EVERY HPI with age, race, and gender (e.g., 34-year-old AA male). You must include the seven attributes of each principal symptom in paragraph form not a list. If the CC was “headache”, the LOCATES for the HPI might look like the following example:

Location: head

Onset: 3 days ago

Character: pounding, pressure around the eyes and temples

Associated signs and symptoms: nausea, vomiting, photophobia, phonophobia

Timing: after being on the computer all day at work

Exacerbating/ relieving factors: light bothers eyes, Aleve makes it tolerable but not completely better

Severity: 7/10 pain scale

Current Medications: include dosage, frequency, length of time used and reason for use; also include OTC or homeopathic products.

Allergies: include medication, food, and environmental allergies separately (a description of what the allergy is ie angioedema, anaphylaxis, etc. This will help determine a true reaction vs intolerance).

PMHx: include immunization status (note date of last tetanus for all adults), past major illnesses and surgeries. Depending on the CC, more info is sometimes needed Soc Hx: include occupation and major hobbies, family status, tobacco & alcohol use (previous and current use), any other pertinent data. Always add some health promo question here – such as whether they use seat belts all the time or whether they have working smoke detectors in the house, living environment, text/cell phone use while driving, and support system.

Fam Hx: illnesses with possible genetic predisposition, contagious or chronic illnesses. Reason for death of any deceased first degree relatives should be included. Include parents, grandparents, siblings, and children. Include grandchildren if pertinent.

ROS: cover all body systems that may help you include or rule out a differential diagnosis You should list each system as follows: General: HeadEENT: etc. You should list these in bullet format and document the systems in order from head to toe.

Example of Complete ROS:

GENERAL:  No weight loss, fever, chills, weakness or fatigue.

HEENT:  Eyes:  No visual loss, blurred vision, double vision or yellow sclerae. Ears, Nose, Throat:  No hearing loss, sneezing, congestion, runny nose or sore throat.

SKIN:  No rash or itching.

CARDIOVASCULAR:  No chest pain, chest pressure or chest discomfort. No palpitations or edema.

RESPIRATORY:  No shortness of breath, cough or sputum.

GASTROINTESTINAL:  No anorexia, nausea, vomiting or diarrhea. No abdominal pain or blood.

GENITOURINARY:  Burning on urination. Pregnancy. Last menstrual period, MM/DD/YYYY.

NEUROLOGICAL:  No headache, dizziness, syncope, paralysis, ataxia, numbness or tingling in the extremities. No change in bowel or bladder control.

MUSCULOSKELETAL:  No muscle, back pain, joint pain or stiffness.

HEMATOLOGIC:  No anemia, bleeding or bruising.

LYMPHATICS:  No enlarged nodes. No history of splenectomy.

PSYCHIATRIC:  No history of depression or anxiety.

ENDOCRINOLOGIC:  No reports of sweating, cold or heat intolerance. No polyuria or polydipsia.

ALLERGIES:  No history of asthma, hives, eczema or rhinitis.

O.

Physical exam: From head-to-toe, include what you see, hear, and feel when doing your physical exam. You only need to examine the systems that are pertinent to the CC, HPI, and History. Do not use “WNL” or “normal.” You must describe what you see. Always document in head to toe format i.e. General: Head: EENT: etc.

Diagnostic results: Include any labs, x-rays, or other diagnostics that are needed to develop the differential diagnoses (support with evidenced and guidelines)

A .

Differential Diagnoses (list a minimum of 3 differential diagnoses).Your primary or presumptive diagnosis should be at the top of the list. For each diagnosis, provide supportive documentation with evidence based guidelines.

P. 

This section is not required for the assignments in this course (NURS 6512) but will be required for future courses.

References

You are required to include at least three evidence based peer-reviewed journal articles or evidenced based guidelines which relates to this case to support your diagnostics and differentials diagnoses. Be sure to use correct APA 6th edition formatting.

© 2019 Walden University Page 1 of 3